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Abbreviation  
Abbreviation  Full name 
(i)OSN (immature) olfactory sensory neuron 
(M)OB (main) olfactory bulb 
(T-)PBS (Triton-) Phosphate buffered saline 
AC3 Adenylyl cyclase 3 
AOB Accessory olfactory bulb 
ATP Adenosine triphosphate 
Big2 Brain-derived, immunoglobulin superfamily molecule-2 
bp Base pairs 
BSA Bovine serum albumin 
caGs Constitutively active Gαs subunit 
cAMP Cyclic adenosine monophosphate 
CIP Calf intestine phosphatase 
CNGC Cyclic nucleotide gated channel 
CV Coefficient of variation 
DNA Deoxyribonucleic acid 
E(number) Embryonic age () 
EPL External plexiform layer 
ES Embryonic stem cell 
EtBr Ethidium bromide 
GAP43 Growth associated protein 43 
GFP Green fluorescent protein 
GG Grüneberg ganglion 
Glom Glomerular layer 
GPCR G protein coupled receptors 
GrL Granule layer 
GTP Guanine triphosphate 
iOSN Immature OSN 
IPL Internal plexiform layer 
IRES Internal ribosomal entry site 
lacZ β-galactosidase 
LB Lysogeny broth 
LB-Crab LB with carbenicilin  
MOE Main olfactory epithelium 
MT Mitral layer 
NaCl Sodium Chloride 
NCAM Neural cell adhesion molecule 
Nrp Neuropilin 
O.C.T. Optimum cutting temperature (freezing medium)  
OCNC1 Cyclic nucleotide gated channel alpha 2 
OMP Olfactory marker protein 
ONL Olfactory nerve layer 
OR Odorant receptor 
PCR Polymerase chain reaction 
PD(number) Post natal day () 
PFA Paraformaldehyde 
RFP Red fluorescent protein 
RNA Ribonucleic acid 
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Abbreviation  Full name 
Robo Round about 
Sema Semaphorin 
SO Septal organ 
TAAR Trace amine-associated receptor 
TGV Total glomerular volume 
V1R VR class 1 
V2R VR class 2 
VNO Vomeronasal organ 
VR Vomeronasal receptor 
YFP Yelllow fluorescent protein 
z-stack Optical sections in the z direction 
β2AR β2-adrenergic receptor 
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1 Summary 
 
Odorant receptor (OR) genes were discovered by Buck and Axel (1991). 
Around 1,100 ORs are expressed in mouse olfactory sensory neurons (OSNs) 
in a monoallelic and monogenic manner (Chess et al., 1994). These OSNs 
are located in the main olfactory epithelium and project their axons to the 
olfactory bulb (OB) where they form homogeneous glomeruli. The glomeruli 
are formed at conserved positions in the OB. Several laboratories have 
studied the mechanisms that guide the OSN axons to their target where they 
form synapses with the mitral cells that convey the olfactory signal to other 
brain regions. Several theories have emerged to explain these mechanisms, 
but none has yet achieved full explanation for the precise axonal wiring in the 
mouse olfactory system. 
 
This thesis describes three approaches for gaining further insight into the 
mechanisms that govern axonal wiring. In the first approach a gene-targeting 
vector was designed to target the M71 locus and knock in the constitutively 
active Gαs subunit (caGs) in M71-expressing OSNs.  It has been reported that 
OSNs expressing caGs shift their glomerular position to a posterior position in 
the OB. However this shift was shown only with transgenic mice. A gene-
targeted expression from the M71 locus would have provided a better 
understanding, because it is closer to the native mechanism. Unfortunately 
the assembly of the targeting vector was more difficult than anticipated and 
the project was suspended after a year.  
 
The second approach was an empirical study of the fundamental 
components of the olfactory system. Green-fluorescent OSNs in 11 gene-
targeted strains coexpressing GFP with a specific OR gene were evaluated 
quantitatively. It was shown that their OSN number is proportional to the 
respective total glomerular volume (TGV). These data enable new methods of 
quantifying and qualifying the properties of the OSN population and allow an 
estimate of the OSN numbers from the easier to measure TGV, which is much 
easier to measure than counting cells. With the first broad collection of 
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complete datasets of the number of OSNs, several other results could be 
extrapolated. The full datasets allowed an in-depth analysis of the sampling 
error for the 11 strains and established a well-grounded threshold for 
sampling of the main olfactory epithelium from every fifth section. I also 
demonstrated that these 11 strains have different stabilities of expression in 
terms of numbers of labeled OSNs, measured by the coefficient of variation 
(CV), with the strain MOR23-IRES-tauGFP being the most stable. It was also 
shown that most of the strains tested have a unique expression pattern along 
the anterior-posterior axis, except for OR-expressing OSNs in the classical 
zone 1, which displayed a similar expression pattern. For this study several 
reporter genes were expressed from the M71 locus, in addition gene 
replacements and downregulation of M71 were measured as well. These 
strains showed differences in the OSN numbers compared to M71-IRS-
taulacZ expressing OSNs. The latter being expressed three times more than 
in the strains expressing fluorescent marker proteins. However each strain 
maintained the characteristic expression pattern for M71. 
 
The final approach discussed in this thesis is the influence of a conditional 
Neuropilin-1 (Nrp1) knockout on axonal wiring of the mouse olfactory system. 
It has been reported that the position of a glomerulus in the OB along the 
anterior-posterior axis is determined by a gradient of Nrp1. However this 
finding was in mice expressing a transgene. Here an approach was chosen to 
generate a better test of this hypothesis. Conditional knockouts of Nrp1 in 
M71-expressing OSNs were generated, exploiting the unusual feature of 
monoallelic expression of ORs to provide a control in the same individual 
mouse. The results show not a gradual shift of glomeruli to the anterior OB as 
reported previously (Imai et al., 2009), but the formation of ectopic glomeruli in 
the anterior bulb, resembling the effect an adenylyl cyclase 3 (AC3) knockout 
has on M71-expressing OSNs. This phenotype is established directly at the 
onset of glomerular formation and is maintained during adulthood. These 
finding leads to the conclusion that the signal transduction cascade of OSNs 
is indeed linked to the expression of Nrp1, but a simple Nrp1-gradient 
hypothesis cannot explain the phenotype M71-expressing OSNs.   
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2 Introduction 
 
Of the five senses the sense of smell is probably the most complex one to 
investigate. While for example the sense of taste has five different receptor 
types to coordinate, the sense of smell has to coordinate hundreds of different 
olfactory sensory neurons (OSNs) each expressing a single odorant receptor 
(OR) gene (Chess et al., 1994). The discovery of the OR genes 24 years ago 
has triggered a substantial amount of research on the mechanism that 
determines and regulates axonal wiring in the mouse olfactory system.  
  
2.1 Anatomy of the mouse olfactory system 
 
The olfactory system of mice consists of several organs, which express 
many types of molecular chemosensory receptors (Figure 2.1). The first of 
these organs is the Grüneberg ganglion (GG), located at the tip of the nose of 
the mouse. The chemosensory neurons there probably express receptors for 
early warning signals (Brechbühl et al., 2008). The vomeronasal organ (VNO) 
is situated on the septum in the nasal cavity and receives mostly information 
from pheromones and kairomones (Døving and Trotier, 1998). The most 
prominent chemosensory receptors in the VNO are the vomeronasal 
receptors (VR) and will be further described in Chapter 2.4. Another sensory 
organ is also situated on the septum, the septal organ (SO). In the SO a 
subset of olfactory sensory neurons (OSNs) can be found (Ma et al., 2003b, 
Tian and Ma, 2004). Most OSNs reside within the main olfactory epithelium 
(MOE). OSNs in SO and MOE send their axons through the cribriform plate to 
the main olfactory bulb (MOB), where they form glomeruli that are 
homogeneous for a single OSNs type. 
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Figure 2.1 Mouse olfactory system 
Representative sagittal map of the mouse olfactory system showing the different sensory organs: 
Grüneberg ganglion (GG), vomeronasal organ (VNO), septal organ (SO) and main olfactory epithelium 
(MOE). OSNs  (small green dots) located in MOE project their axons to the mouse olfactory bulb (MOB) 
to form homogeneous glomeruli (large green circle). 
   
 
2.2 Olfactory receptors (ORs) and olfactory sensory neurons 
(OSNs) 
 
The OR gene family is the largest gene family in the mammalian genome. 
It was discovered by Linda Buck and Richard Axel in 1991 (Buck and Axel, 
1991) and recognized with the 2004 Nobel Prize in Physiology or Medicine. 
The OR genes are expressed in OSNs monogenically and monoallelically 
(Chess et al., 1994), which makes them an interesting model for the study of 
gene choice. Recent studies estimate that approximately 10 million mature 
OSNs are present in an eight-week old mouse (Kawagishi et al., 2014).  
 
Most OSN cell bodies reside within the middle layer of the main olfactory 
epithelium (Strotmann et al., 1996). The MOE is layered from basal to apical 
along the maturation of OSNs (Nickell et al., 2012). The basal layer provides 
the progenitor OSNs, which develop to immature OSNs (iOSNs), determined 
by the expression of GAP43. Mature OSNs are detected by their expression 
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of the olfactory marker protein (OMP) and they are situated in the apical half 
of the epithelium (Figure 2.2). 
 
 
Figure 2.2 Olfactory epithelium layers 
Schematic overview of the layers in the main olfactory epithelium from apical to basal along a coronal 
section of aPD21 M71-IRES-tauGFP mouse taken with a confocal microscope. OSN progenitor cells are 
formed from the basal cells (grey). While maturing the immature OSNs (light green) express GAP and 
move in apical direction. Dendrite and axon begin to form. Cell bodies of mature OSNs (green) are in 
the apical half of the epithelium. They have fully formed dendrites crossing the sustentacular cell layer 
and cilia spreading on the apical side. Mature OSN axons project to the olfactory bulb. The mature OSN 
layer is characterized by OMP expression. Scale bar: 20 µm 
 
 It has been established that OSNs expressing a specific OR are not 
spread homogeneously across the whole surface of the MOE. The first 
studies identify four discrete zones of expression, arranged roughly from 
dorsal to ventral MOE (Ressler et al., 1993). Later studies gave rise to the 
idea that each OR-expressing OSN population is expressed in a unique 
gradient across the epithelium (Miyamichi et al., 2005). Recent unpublished 
studies in our lab suggest an intermediate scenario. The OR gene family can 
be divided into two classes. Class I ORs are expressed exclusively in the 
dorsal area and project to anterior-dorsal region of the bulb (Tsuboi et al., 
2006), while class II ORs are expressed in all zones of the MOE (Figure 2.3). 
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Figure 2.3 Illustration of zones and gradients 
This sketch illustrates the difference between the theory of OSN expression in zones and in gradients. 
For zonal expression each OSN population (green & red) is confined to a specific zone (historical four 
with the green are representing zone 1 and the red area zone 2). Each OSN population would fall in one 
of these zones. In the gradient theory each OSN population would be expressed preferentially also in its 
own zone, however, also in a stripe overlapping with the zones of one or more other OSN population. 
 
Since 1991, approximately 1,100 OR genes have been identified in mouse 
(Zhang and Firestein, 2002), located on most chromosomes. The structure of 
these ORs contains seven-transmembrane spanning regions, similar to other 
G-protein coupled receptors such as the β2 adrenergic receptor, but there is a 
substantial variance in sequence (Liu et al., 2003). ORs are expressed 
already very early in development and can be detected by antibody staining 
as early as embryonic age 12 (E12) in cilia of OSNs (Schwarzenbacher et al., 
2005). These receptors are not only expressed in the cilia of the OSNs but 
can also be detected in their axon terminal (Barnea et al., 2004 , Strotmann, 
2004). Ca2+ influx and cyclic adenosine monophosphate (cAMP) as second 
messenger in the signaling cascade (Maritan et al., 2009) were also observed 
in early OSNs.   
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The zonal expression of a population of OSNs as well as the regulation of 
monogenic expression of the ORs in OSNs is still not fully understood. 
Several groups have been working on the issue of gene choice and the 
regulation of OR expression and suppression. Once an OR is chosen and 
successfully expressed, the OSN never changes this chosen OR. However 
there are no genetic alterations of the OR locus accompanying gene choice 
(Li et al., 2004). Expression of a functional receptor is important for a stable 
expression of this OR through the OSNs life. If the OR is not functional 
another OR gene is chosen for expression (Shykind et al., 2004). However 
the alternate choice does not have to originate from the same gene clusters, 
as shown with the highly related mOR37 gene cluster (Bader et al., 2010). 
The OR sequence is sufficient for silencing expression other OR genes 
(Nguyen et al., 2007) even from transgenic ORs. The sequence of 
untranslatable OR mRNA is sufficient for an effective silencing of other ORs 
(Lewcock and Reed, 2004). There is a hierarchy in the choice of an OR 
(Hirota et al., 2007) where the class is determined before the specific OR.  
 
Recently several factors regulating the gene choice haven been discovered. 
The regulatory element called the P element was reported in 2011 in this lab 
(Khan et al., 2011). The structure of OR promoters has been revealed a year 
later (Plessy et al., 2012). The first initiator for OR expression has been 
discovered, with downregulation of LSD1 associated with stabilization of OR 
gene choice (Lyons et al., 2013).    
  
2.3 Oddities of OSN populations  
 
Of the ~1,100 ORs in mouse only a few percent have been characterized 
in some detail. But already several OSN populations are reported to have 
remarkable and so far unique expression patterns. For example OSNs 
expressing the receptor SR1, which represent one of the largest OSN 
populations, constitute half of all OSNs situated in the septal organ (Tian and 
Ma, 2004, Figure 2.4). This broad expression is even more interesting since 
SR1 has a very broad response profile for an OR (Grosmaitre et al., 2009). 
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Another interesting gene family is the mOR37 gene family, with an unusual 
expression pattern in a patch in the middle of the MOE on one turbinate. 
However a transgene expression of the mOR37C leads to expression of the 
OR outside of this patch (Strotmann et al., 2009, Bader et al., 2010).  
 
 
Figure 2.4 Example of SR1 expression in the septal organ 
Confocal image of coronal 12 µm section of the septal organ of a PD21 SR1-IRES-tauGFP mouse. Both 
images are from the same coronal section; the septum was removed. Green intrinsic fluorescence 
shows OSNs expressing SR1. The strong green fluorescent lines close to the septum are the axon 
bundles heading towards to the olfactory bulb. DAPI staining in grey. Scale bar: 20 µm. 
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2.4 TAARs & VRs 
 
Olfactory receptors are not the only chemosensory receptor families 
expressed in the olfactory system. Another family is the vomeronasal 
receptors (VRs), which are expressed in the vomeronasal organ (VNO) that is 
situated on the septum and senses pheromones. VR genes are the largest 
receptor gene family expressed in VNO, constituting almost all of the sensory 
neurons. VRs can be divided into two subfamilies (called V1R and V2R). 
V1Rs are expressed in the apical VNO epithelium while V2Rs are expressed 
in the basal VNO epithelium. Their axons project to the accessory olfactory 
bulb (AOB) situated dorsally and posterior of the MOB (Figure 2.5). The 
separation between V1R and V2R is still maintained in the AOB, the V1R 
glomeruli occupying the dorsal half of AOB while the V2R glomeruli occupy 
the ventral half of the AOB. But compared to the OSNs, only V1Rs are 
expressed similarly in a monogenic fashion, while V2Rs are not (Roppolo et 
al., 2007). It is also interesting to note that in mouse subspecies the VR 
repertoire differs in terms of the functional VR genes (Wynn et al., 2012). 
 
 
Figure 2.5 Axonal wiring of the vomeronasal system 
Schematic overview of the axonal wiring of the VNO to the AOB in sagittal view. The VNO in coronal 
view (box) consists of cavernous tissue (grey), basal epithelium with V2Rs (orange) and apical 
epithelium with V1Rs (red). Both chemosensory neuron types send their axons to representative zones 
in the AOB. V1R to the dorsal half and V2R to the ventral half of the AOB. 
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Another recently discovered gene family is expressed in the MOE, the 
trace amine-associated receptors (TAARs). They are coexpressed with ORs 
but have the same signal transduction cascade, the Gα olfactory subunit 
(Gαolf), as mature OSNs (Liberles and Buck, 2006). They are closely related to 
OR genes, explaining this similarity (Pacifico et al., 2012). It has been shown 
that TAAR-expressing sensory neurons respond to the odors of predators and 
other odors that trigger aversive reactions (Dewan et al., 2013). If a TAAR 
gene is deleted, TAAR expressing sensory neurons tend to express other 
TAARs rather than ORs. TAAR-expressing neurons project to a dorsal area in 
MOB, in between the areas D1 and D2. It seems that TAAR-expressing cells 
do not maintain such a strict homogeneity in their glomeruli as OSNs do 
(Pacifico et al., 2012).  
 
2.5 Signaling 
 
The primary task of a functional OR is the detection of odorants. Since ORs 
are G-protein coupled receptors (GPCRs) the molecular events following 
binding of an odorant by the OR are similar to other GPCRs and were 
established shortly after the discovery of the ORs themselves (Levy et al., 
1991). The ORs are expressed early in development at E12.  Other important 
factors such as NCAM and Big2 are expressed at E11 and E14, respectively 
(Saito et al., 1998).  
If an odorant is bound to an OR, the the Gα subunit is activated by binding 
a GTP (guanosine tri-phosphate). In immature OSNs the activation is by the 
Gαs subunit, while after E14 (Saito et al., 1998) the Gαolf subunit is used for 
signal transduction (Figure 2.6).  
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Figure 2.6 Signal transduction in OSNs 
Schematic overview of the signaling transduction cascade in OSNs. Odorant is bound by OR. The Gα 
subunit (either Gαs in inmature or Gαolf in mature OSNs) is activated and in turn activates AC3. AC3 will 
transform ATP into the second messenger cAMP, which will then activate kinase towards the growth 
cone and/or transcription factors. cAMP will also open CNG channels, where the Na+ and Ca2+ influx 
causes a depolarization of the cell membrane which will ultimately lead to an action potential. 
 
The activated Gαolf subunit is binding the adenylyl cyclase 3 (AC3), which 
transforms adenosine triphosphate (ATP) to cAMP. The second messenger 
cAMP is the critical signaling molecule in OSNs (Firestein et al., 1991). Mice 
with a knockout of the AC3 gene have viable OSNs but multiple ectopic 
glomeruli are formed and wiring defects are seen (Zou et al., 2007). AC3 and 
Gαolf are also the first steps in the signal transduction cascade in the septal 
organ, supporting further the close relationship between the SO and MOE (Ma 
et al., 2003a). However, the same cascade does not apply to the VNO. For 
instance, Gαolf could not be detected in the VNO, but low traces of AC3 were 
found (Berghard et al., 1996). Consequently, the VNO can still detect odors 
and pheromones even after a deletion of AC3 (Trinh and Storm, 2003). 
 
The primary targets for the second messenger cAMP in the signaling 
cascade are the cyclic nucleotide gated (CNG) channels. When cAMP binds 
to the CNG channels, they open and allow the influx of sodium (Na+) and 
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calcium (Ca2+) ions. This influx of cations leads to a depolarization of the 
membrane and ultimately to the formation of action potentials. The 
depolarization is further supported by the opening of chloride ion (Cl-) 
channels. The critical role of CNG channels is emphasized by a deletion of 
CNG channels in mice, resulting in profound anosmia (Brunet et al., 1996). 
 
Three studies report other interesting observations concerning the 
modulation of the signal transduction cascade in OSNs. The first study shows 
that a complex of ORs with other GPCRs strengthens the localization of all 
GPCRs in the plasma membrane (Bush et al., 2007). The second study 
identifies Pl3k as a mediator of inhibitory signaling in OSNs (Ukhanov et al., 
2010). Pl3k is enforcing G-protein signaling and thus Pl3k expression leads to 
a faster rise time of the signaling cascade and stronger negative feedback to 
suppress expression of other ORs. The third study shows that OR expression 
increases AC3 expression, which then makes OR choice permanent (Dalton 
et al., 2013).  
   
2.6 Development 
 
Since the sense of smell is one of the most important senses for mice after 
birth and later in life, it is not surprising that ORs are expressed early in 
development and that OSNs mature quickly. The first expression of ORs (for 
example MOR256-17) can be detected by E12 in the dendritic knob 
(Schwarzenbacher et al., 2005). By E13 most ORs are expressed, but in 
unique, adult-like patterns and with an unique timing (Rodriguez-Gil et al., 
2010). At the same time (E11-14) OSNs can also be detected in the cribriform 
mesenchyme, where they are thought to support the projecting axons from 
the epithelium to the olfactory bulb (Schwarzenbacher et al., 2004). About two 
days later in development, at E15.5, the first axons (shown for P2-IRES-
taulacZ) can be detected in the OB (Royal and Key, 1999). OSNs are fully 
responsive by E16.5 (shown for S1 and MOR23) and glomeruli start forming 
directly after birth (Lam and Mombaerts, 2013). The OB interneurons move to 
the bulb at E14.5 and differentiate by PD21. Their identity is autonomously 
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defined in the lateral ganglionic eminence (LGE) and is irreversible (Tucker et 
al., 2006). 
 
Even with the onset of OR expression in early development, the 
development still continuess to mature age at 10-12 weeks (Pomeroy et al., 
1990). The population of M72-expressing OSNs is maintained and stable and 
their glomerular number is consistent even after 24 months after birth 
(Richard et al., 2010). 
The maturation is dependent on the activity of the OSNs, especially in 
glomerular formation. The M71 and M72 glomeruli were reported to become 
more homogeneous with development, from PD10 to PD60 (Zou et al., 2004). 
Glomerular development can be accelerated by odor training and exposure 
(Kerr and Belluscio, 2006).  
OSNs maintain their plasticity even at old age (Jones et al., 2008). After 
naris closure, the OSN number and glomerular volume for P2-expressing 
OSNs do recover (Cummings and Belluscio, 2010).  
      
2.7 Axonal wiring  
 
One of the most impressive feats in the mouse olfactory system is the 
precise projection of OSN axons to the olfactory bulb to form glomeruli 
(Ressler et al., 1994). These glomeruli are formed homogeneously by axons 
of OSNs expressing the same OR (Treloar et al., 2002), illustrated as an 
example in Figure 2.7). All OSN populations project their axons to conserved 
positions in the olfactory bulb (Figure 2.8). Before reaching the position of 
their glomeruli the axons travel across the outer olfactory nerve layer until 
they are close to the glomerular position (Au et al., 2002), branching only 
within the glomerular position (Klenoff and Greer, 1998). Other axons 
expressing the same OR are needed for glomerular stability (Ebrahimi and 
Chess, 2000). Glomeruli start forming after birth and their number increases 
until more than 12 weeks after birth (LaMantia et al., 1992, Pomeroy et al., 
1990). The general position of the glomeruli for a given OSN population is 
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consistent but the number of glomeruli varies in some populations, for 
example in P2-expressing OSNs (Schaefer et al., 2001). 
 
 
Figure 2.7 SR1-IRES-tauGFP glomerulus 
Two-photon microscope image of SR1-IRES-tauGFP PD21 mouse shows a lateral glomerulus. This 
image shows how the axon bundles project and form the characteristic homogeneous, round structure 
of a glomerulus. This image was reconstructed from z-stacks images with intrinsic fluorescence of GFP-
expressing OSNs. Scale bar: 250 µm. 
 
 
Figure 2.8 Axonal projection of M71 
Sagittal whole mount of M71-IRES-taulacZ PD21 shows the projection of M71-expressing OSNs to the 
olfactory bulb where they form one glomerulus per half-bulb. OSNs and axons were visualized by x-gal 
staining. Scale bar: 500 µm. 
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Nearly quarter of a century after the discovery of the ORs the mechanisms 
that govern this precise axonal wiring are not fully understood. In recent years 
several factors that modify the glomerular position or axonal wiring in general 
have been discovered. For instance several knockouts in parts of the signal 
transduction cascade in mice have interesting effects on axonal wiring. 
Silencing of an OR by mutating the N terminal G protein binding site with a 
RDY mutant abolishes glomerular formation in rat I7-expressing OSNs in 
transgenic mice (Imai et al., 2006). This phenotype can be rescued with the 
expression of a constitutively active Gαs subunit (caGs). CaGs does not need 
to bind to the GPCR to initiate a signal transduction event and thus can 
maintain cAMP level even with a silent OR. The most prominent effects are 
reported for a knockout of AC3, resulting in a disturbed axon wiring. For all 
OSNs tested in an AC3-deficient background, the axonal wiring was found to 
be perturbed leading to the formation of ectopic glomeruli or abolishing the 
formation of glomeruli even when the axons project to the correct position 
(Zou et al., 2007). An AC3 deletion also perturbs the fine axon sorting in the 
glomerular layer (Chesler et al., 2007). The same article also shows that even 
the ectopic expression of Gαolf can be sufficient to establish a unique 
glomerular position. A knockout of β3GnT2, which modifies AC3, leads to 
defects in axonal wiring (Henion et al., 2011). Surprisingly a knockout of CNG 
still leads to fairly normal axonal wiring in the OB even though the 
depolarization as a result of the signal transduction cascade is abolished (Lin 
et al., 2000). However a conditional knockout of OCNC1 (a subunit of the 
CNG, now known as Cnga2) leads to miswiring and multiple, ectopic 
glomeruli for M72 neurons (Zheng et al., 2000). In the OCNC1 knockout strain 
these nonfunctional OSNs die due to the lack of function, however if 
combined with naris closure the non functional OSNs are not replaced (Zhao 
and Reed, 2001).  
 
Another important factor for axonal wiring is the OR sequence itself. 
Several articles have reported on the effect of replacing the OR genetic 
sequence with another and the consequences for axonal wiring. The first 
study in that regard was published in 1996 and showed that by replacing the 
P2 sequence with M71, labeled axons form glomeruli but at a different 
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position (Mombaerts et al., 1996). This gene replacement experiment was 
performed next with P3, M71 or M50 into the P2 locus: in each case, the 
axons still form glomeruli but at a different position (Wang et al. 1998). These 
positions are different from the P2 position and the normal position of the 
replacing OR, mostly somewhere in between the two positions (Mombaerts et 
al., 1996; Wang et al., 1998). Only when the OR sequence is closely related 
to the native OR sequence, for example in the case of M71 and M72, it is 
possible to shift the glomerular position completely to the position 
characteristic for the replacing OR (Feinstein and Mombaerts, 2004). But in 
most cases the OSNs with a replaced OR form glomeruli at novel position in 
the OB, as shown for the rat I7 in M71 (Bozza et al., 2002) and M72 in S50 
(Bozza et al., 2009; Zhang et al., 2012). Even a single nucleotide substitution 
can shift glomerular position (Feinstein and Mombaerts, 2004). A non–
olfactory GPCRs can substitute as an OR when put in an OR locus: the β2 
adrenergic receptor (β2AR) expressed from the M71 locus can support the 
formation of glomeruli (Feinstein et al., 2004, Omura et al., 2014). Another 
interesting effect was shown with an intricate downregulation of M71 
expression. In this gene-targeted strain the M71 sequence was flanked by 
fluorescent marker proteins and behind an IRES site. Genes downstream of 
an IRES site are expressed less well. This so-called hypomorph shows an 
anterior shift in glomerular position (Feinstein et al., 2004) even though the 
OR sequence is identical. All gene replacements described have the 
functional responsiveness of the replacing OR (Bozza et al., 2002) but the 
hypomorph has a reduced responsiveness compared to M71-expressing 
OSNs (Zhang et al., 2012). Several transgenic strains expressing ORs have 
been established, either forming glomeruli in the same position as the OSN 
populations that normally express these ORs (Vassalli et al., 2002, Rothman 
et al., 2005) or not (Nakatani et al., 2003, Miyamichi et al., 2005). Modification 
of the homeodomains upstream of M71 show that axonal wiring can be shifted 
or perturbed even if the OR is still expressed (Rothman et al., 2005). 
Accordingly the O/E proteins, which bind Olf1 sites found in promoter regions 
of genes in OSN development such as OMP, are important for correct axonal 
wiring (Wang, 2004).  
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Surprisingly mitral cells, which form the first synapse with the axons of 
OSNs in the glomerular layer, are not important for glomerular formation 
(Royal et al., 2002). Even with an aberrant organization of the postsynaptic 
mitral cells in the olfactory bulb, P2-IRES-taulacZ-expressing OSNs project to 
their typical position. Likewise the GABAergic interneurons are not necessary 
for glomerular formation (Bulfone et al., 1998). However it is important to note 
that the glomeruli of a single OSNs population are functionally connected 
within the OB. The activity in a glomerulus does not only inhibit their 
neighboring glomeruli via lateral inhibition fine tuning their postsynaptic 
mitral/tufted cells (Tan et al., 2010) but also inhibit their corresponding 
glomerulus in the same bulb (Lodovichi et al., 2003). It has been shown for 
M71-expressing OSNs that their glomerulus is bilaterally connected via the 
anterior olfactory nucleus pars externa (Yan et al., 2008).  
 
One further explanation for the precise and homogeneous axonal wiring is 
found in the diverse expression of cell adhesion molecules, marker proteins 
for regions of the epithelium and cell surface molecules. Similarly, the 
olfactory cell adhesion molecule (OCAM) expressed in OSNs in the ventral 
region of the MOE, which project to the ventral region of the OB. OCAM is 
however not needed for axonal wiring per se, but for establishing a fine axonal 
sorting and subcompartments within a glomerulus (Walz et al., 2006). Other 
molecules, like neurotropin-3 (NT-3) and transient receptor potential M 5 
(TrpM5), are also differentially expressed by OSNs, but the role of these 
molecules is not resolved (Rolen et al., 2014). The protein Big-2 is 
differentially expressed in the OB and is reported to mediate olfactory axon 
convergence (Kaneko-Goto et al., 2008). Another cell adhesion molecule 
called Gicerin is differentially expressed in the OB at E17.5 (Williams et al., 
2007). Again its role remains to be determined.  
 
Several prominent cell adhesion molecule systems are also expressed in 
the olfactory system and play an important role in axonal wiring. For example 
the roundabout (Robo)/Slit complex is important in early axonal wiring. If Robo 
1, which is expressed in ensheathing cells, is deleted, the axons are stopped 
from reaching the dorsal OB and axonal wiring is perturbed. However this 
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effect was only shown in transgenic mice, expressing β2AR from the MOR23 
promoter (Aoki et al., 2013). In Robo-2 or Slit-1 knockout mice, OSNs residing 
in zone 1 do not project their axons to the dorsal bulb but form glomeruli in the 
ventral region of the bulb (Cho et al., 2007). In Robo-1 and Robo-2 double 
knockout embryos (E16-18) most OMP positive axons fail to reach the OB. 
However MOR256-17-expressing OSNs still form ectopic homogeneous 
glomeruli in Slit-1 and Slit-2 double knockout as well as in Robo-1 and Robo-2 
double knock out mice at E18 (Nguyen-Ba-Charvet et al., 2008). These 
results show that Robo/Slit is an important but broadly applied factor in the 
dorsal/ventral axonal wiring in mouse.  
 
Another factor in the dorsal/ventral patterning is the cell adhesion molecule 
Neuropilin 2 (Nrp2) and its repulsive ligand Semaphorin 3F (Sema3F). Nrp2 
has been reported to be expressed in a gradient increasing in ventral direction 
and a knockout of Nrp2 will shift glomerular position dorsally (Takeuchi et al., 
2010). Another study shows that a knockout of Nrp2 mostly influences OSNs 
expressed in the classical zone 4 of the MOE. In Nrp2 knockout mice, OSNs 
expressing MOR28 and I7 start forming multiple and partly ectopic glomeruli 
but this result was shown with two mice (Takahashi et al., 2010).  
 
As stated before, intact activity of OSNs is an important factor for the 
formation of homogeneous glomeruli. For example, an overexpression of the 
inward rectifying potassium channel Kir2.1 diminishes the excitability of OSNs 
and severely disrupt glomerular formation (Yu et al., 2004). Two pairs of cell 
adhesion molecules play a crucial role in the fine sorting of the axons and 
maintaining homogeneity: Kirrel2/Kirrel3 (self adhesive) and Eph-A5/Ephrin-
A5 (repulsive effect) are activity dependently expressed and support fine 
axonal sorting in glomerulus (Serizawa et al., 2006). A knockout of Ephrin-A3 
and Ephrin-A5 shifts glomeruli of OSNs expressing SR1 and P2 to a more 
posterior position in the OB (Cutforth et al., 2003).  
 
The last group of differentially expressed molecules, and least studied, is 
cell surface carbohydrates (glycans). For example, the cell surface 
carbohydrates UEA and DBA are expressed in conserved patterns in the 
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MOB. However these patterns are not correlated with glomeruli of OSNs 
expressing M71 or P2 (Lipscomb et al., 2003). UEA is expressed in subset of 
cells in MOE forming several small microglomeruli, which appear to be a 
different population to AOE glomeruli and OR glomeruli (Lipscomb et al., 
2002b). The lectin DBA is differentially expressed in glomeruli and can be 
detected with different intensities in the glomerular layer of the bulb. But there 
are OMP-negative and DBA-positive axons contributing to these glomeruli 
(Lipscomb et al., 2002a). Finally a knockout of the β3GnT1, which regulates 
extension of lactoseamines in glycans, results in cell death of OSNs and 
impaired wiring (Henion et al., 2005). 
 
2.8 Neuropilin-1  
 
The cell adhesion molecule Neuropilin 1 (Nrp1) is for one of the most 
promising contenders for establishing the anterior/posterior glomerular 
position of glomeruli in the MOB. Nrp1 is differentially expressed in the MOE 
and MOB (Pasterkamp et al., 1998). OCAM and Neuropilin-1 form distinct and 
different patterns in the MOB (Nagao et al., 2010). Nrp1 is also expressed in 
sensory neurons in the Grüneberg ganglion. It has been shown that it is 
needed for axonal wiring (Matsuo et al., 2012). Nrp1 forms a complex with 
Plexin A1 and detects the repulsive ligand Semaphorin 3A (Sema3A). This 
complex is sufficient for Sema3A detection, but the expression level of Nrp1 is 
increased in the presence of Plexin A1 (Takahashi et al., 1999). The soluble 
Sema3A has been shown to be important for axon sorting. It is expressed in a 
spiral pattern around the rostro-caudal axis in the MOB. Nrp1 is expressed in 
a contrary pattern (Schwarting et al., 2000). A knockout of Sema3A perturbs 
axonal wiring of P2-expressing OSNs. Lack of Sema3A results in formation of 
multiple glomeruli and their characteristic position is not maintained 
(Schwarting et al., 2004). Expression of Sem3A is involved in reducing cAMP 
levels in vitro, giving a clue about the relation between the signal transduction 
cascade and the expression of cell adhesion molecules, but these results 
have yet to be confirmed in OSNs (Shelly et al., 2011). A popular theory has 
emerged in the last years that a gradient of Nrp1 is the sole determinant of the 
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glomerular position along the anterior-posterior axis, while the finer sorting is 
activity-dependent mediated by fine sorting through Kirrel2/EphA5 and 
Kirrel3/ephrin-A5 (Imai and Sakano, 2008). A conditional knockout of Nrp1 
initiated from a transgene expressed rat I7 OR from mouse MOR23 promoter 
shifts glomerular position more anteriorly, whereas expression of caGs in 
these OSNs shifts the glomeruli more posteriorly (Imai et al., 2009). The 
proposed model is that the basal activity of an OR in development mediated 
by the Gαs subunit is involved in regulating cAMP levels in a gradient manner 
(Nakashima et al., 2013). However this explanation cannot explain all the 
results of the AC3 knockout (Zou et al., 2007), which has a distinct phenotype 
of ectopic glomerular formation for the M71- or M72-expressing OSNs. In 
addition, recent studies showed that OSNs expressing M71 and MOR23 have 
similar spontaneous activity (Connelly et al., 2013) although the glomerular 
position is very different in the MOB (Col et al., 2007). 
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3 Materials 
 
3.1 Animals 
 
Most strains used in this thesis were generated by the lab of Dr. Peter 
Mombaerts using the method of gene targeting described in (Mombaerts et al., 
1996), where a target sequence in the genome is replaced with a modified 
sequence by homologous recombination in mouse embryonic stem cells. 
Most strains contain an internal ribosomal entry site (IRES). This sequence 
originates from the encephalomyocarditis virus and enables coexpression of 
two genes from a single mRNA transcript (Kaminski et al., 1990). This IRES is 
used to coexpress a reporter gene, such as GFP, under the same promoter 
simultaneously with the gene of interest, such as an OR.  
  
Mice were maintained in specified pathogen-free conditions in individually 
ventilated cages of the Tecniplast green line (Tecniplast, Italy). Mice received 
ad libitum gamma-irradiated ssniff V1124-727 (ssniff, Soest, Germany). 
Nesting, bedding, and enrichment were provided as nestpak, Datesand Grade 
6 (Datesand, Manchester, United Kingdom). Mouse experiments were carried 
out in accordance with the German Animal Welfare Act, European 
Communities Council Directive 2010/63/EU, and the institutional ethical and 
animal welfare guidelines of the Max Planck Institute of Biophysics and the 
Max Planck Research Unit for Neurogenetics. Approval came from the 
Regierungspräsidium Darmstadt, and the Veterinäramt of the city of Frankfurt.  
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Table 3.1 List of strains 
Strain name Reference Availability 
P3-IRES-tauGFP  Feinstein and 
Mombaerts, 2004, 
http://jaxmice.jax.org/strain/006684 
M71-IRES-tauGFP  Bozza et al., 2002, 
Feinstein et al., 2004;  
http://jaxmice.jax.org/strain/006676 
mOR37C-IRES-tauGFP  Strotmann et al., 2000,  http://jaxmice.jax.org/strain/006641 
S50-IRES-tauGFP  Bozza et al., 2009,  http://jaxmice.jax.org/strain/006712 
MOR23-IRES-tauGFP  Vassalli et al., 2002,  http://jaxmice.jax.org/strain/006643 
M72-IRES-tauGFP  Potter et al., 2001,  http://jaxmice.jax.org/strain/006678 
M50-IRES-GFP-IRES-
taulacZ  
Feinstein and 
Mombaerts, 2004,  
http://jaxmice.jax.org/strain/006686 
mI7-IRES-tauGFP  Bozza et al., 2002,  http://jaxmice.jax.org/strain/006664 
P2-IRES-tauGFP  Feinstein and 
Mombaerts, 2004,  
http://jaxmice.jax.org/strain/006669 
SR1-IRES-tauGFP  Fuss et al., 2013,  http://jaxmice.jax.org/strain/006711 
MOR256-17-IRES-
tauGFP  
Khan et al., 2011,  http://jaxmice.jax.org/strain/007762 
 β2AR➝M71-IRES-
tauGFP  
Omura et al., 2014,  http://jaxmice.jax.org/strain/006734 
RFP➝M71iM71iGFP  Feinstein et al., 2004,  http://jaxmice.jax.org/strain/006689 
M71-IRES-tauYFP  unpublished http://jaxmice.jax.org/strain/006746 
M71-IRES-tauRFP2  Li et al., 2004,  http://jaxmice.jax.org/strain/006679 
M71-IRES-Cre  Li et al., 2004,  http://jaxmice.jax.org/strain/006677 
Z/EG  Novak et al., 2000,  http://jaxmice.jax.org/strain/00417 
Nrp-1-flox/J  http://jaxmice.jax.org/strain/005247 
Npn1-5247  Gu et al., 2003, same as Nrp-1flox but directly obtained 
from Jackson Lab JR#5247 
I7(WT)-Cre Imai et al., 2006, RBRC02932 
ROSA-STOP-tauLacZ   unpublished 
OMP-Cre  Li et al., 2004,  http://jaxmice.jax.org/strain/006668.html 
OMP-tauSTOPlacZ  unpublished 
R26-tauGFP  Unpublished, Uli Boehm, Hamburg 
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3.2 Chemicals 
 
3.2.1 Molecular Biology 
 
Chemicals Provider 
Plates  Mombaerts lab 
Carbenicilin Sigma-Aldrich, St. Louis MO, USA 
Primers  ThermoFisher Scientific, Waltham, MA, 
USA & eurofins MWG, Ebersberg 
Restriction enzymes & Buffers 
(EcoRI, NcoI, PacI, AscI, 
HindIII, KpnI, PmeI, NotI, XhoI, 
KapnI, SacI, SacI-HF,  SacII, 
XbaI, EagI)  
NEB, Ipswich, MA, USA 
Vectors 
 pBluescript K+  
  
pGEMT easy vector  
Vectors 
Agilent Technologies, Waghaeusel-
Wiesental 
 Promega, Madison, WI, USA 
T4 Ligase & Buffer  Promega, Madison, WI, USA 
Sequencing service  QIAGEN, Hilden 
QIAprep Spin Mini Prep  QIAGEN, Hilden 
QIAfilter Plasmid Midi Kit QIAGEN, Hilden 
QIAGEN Large-construct Kit QIAGEN, Hilden 
QIAquick Gel extraction Kit  QIAGEN, Hilden 
Competent cells  
 dH5α 
 XL2-Blue Ultracompetent cells  
  
MAX efficiency DH5a  
Competend cells  
 Life Technologies GmbH, Darmstadt 
 Agilent Technologies, Waghaeusel-
Wiesental  
 Life Technologies GmbH, Darmstadt 
SOC Medium Life Technologies GmbH, Darmstadt	  
Hyperladder II  Bioline, Luckerwalde 
Phusion Polymerase  Finnzyme, Finnland and ThermoFisher 
Scientific, Waltham, MA, USA 
Gel extraction kit QIEX Gel extraction kit QIEX  
2-log DNA ladder  NEB, Ipswich MA, USA 
Ligation kit long  Takara Bio Inc, Shiga, Japan 
Isopropanol  Sigma-Aldrich, St. Louis, MO, USA 
Ethanol Sigma-Aldrich, St. Louis, MO, USA 
CIP  NEB, Ipswich MA, USA 
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LB media and plates were provided by the institute. They were made 
according to the following recipe (Table 3.2).  
 
Table 3.2 MPI recipes 
LB Medium Agar Plates 
10 g Tryptone (Fluka, 95039-1KG-F) LB Broth with agar (SIGMA L7025-
500TAB) 1Tablet per 50 ml 
5 g Yeast Extact (Fluka, 70161-500G) 1 ml Carbenicillin (25 mg/ml) per 500 
ml 
10 g NaCl (Roth, 3957.5)  
In 1L H20  
 
3.2.2 Genotyping 
 
Material Provider 
Taq Hot Start Takara Bio Inc, Shiga, Japan 
Primer  Sigma-Aldrich, St. Louis MO, USA  
dNTPS  Takara Bio Inc, Shiga, Japan 
10x Reaction Buffer  Takara Bio Inc, Shiga, Japan 
Proteinase K  Bioline, Luckerwalde 
Digestion buffer  Peqlab, Erlangen 
Agarose  Carl Roth  + Co. KG, Karlsruhe 
Ethidium Bromide (EtBR) Carl Roth  + Co. KG, Karlsruhe 
Standard NEB, Ipswich, MA, USA 
Tris Borate EDTA (TBE) 10x 
Stock 
Carl Roth  + Co. KG, Karlsruhe 
Tris Acetate EDTA (TAE) 50x 
Stock 
Carl Roth  + Co. KG, Karlsruhe 
Loading dye 	   Life Technologies GmbH, Darmstadt 
 
3.2.3 Antibody staining  
 
Material Provider 
Normal Donkey Serum  Jackson Immuno Research, Newmarket 
Suffolk, UK 
Normal Goat Serum  Jackson Immuno Research, Newmarket 
Suffolk, UK 
Bovine Serum Albumin  Sigma-Aldrich, St. Louis, MO, USA 
Triton  Sigma-Aldrich, St. Louis, MO, USA 
Parafilm  Parafilm, Oshkosh, WI, USA 
Citrate Buffer  Sigma-Aldrich, St. Louis MO, USA 
DAPI  Life Technologies GmbH, Darmstadt 
Moviol  Calbiochem, EMD Chemicals, San Diego, 
CA, USA 
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3.2.4 Antibodies 
 
Primary Antibody Recommended 
concentration 
Provider (serial number) 
Chicken anti GFP  1:500 Abcam (ab13970) 
Chicken anti β-gal  1:1000 Abcam (ab9361) 
Chicken anti M71  1:500-1:3000 Abcam (ab65573) 
Rabbit anti dsRED  1:250 Clontech (632496) 
Rabbit anti Neuropilin1  1:200 Abcam (ab25998) 
Goat anti Neuropilin1  1:100 R&D Systems ( AF566)  
 
Secondary Antibody Recommended 
concentration 
Provider (serial number) 
ALEXA 488 Goat anti 
Chicken  
1:500   Invitrogen (A11039) 
ALEXA 546 Donkey anti 
Chicken  
1:500 Invitrogen  
Rhodamin Red-X (RRX) 
Donkey anti Rabbit 
1:500 Jackson (711-295-152) 
Fluorescein (FITC) 
Donkey anti Chicken 
1:500 Jackson (703-545-155) 
Cy5 Donkey anti Goat  1:500/1:200 Jackson (705-175-147) 
ALEXA 546 Donkey anti 
Goat  
1:500 Invitrogen (A11056) 
ALEXA 488 Goat anti 
Chicken  
1:500 Invitrogen (A11039) 
ALEXA 488 Goat anti 
Rabbit  
1:500 Invitrogen (A11034) 
ALEXA 546 Goat anti 
Rabbit  
1:500 Invitrogen (A11010) 
 
DyLight 488 Goat anti 
Chicken  
1:500 Bethyl Laboratories (A30-
206D2) 
ALEXA 555 Donkey anti 
Rabbit 
1:500 Invitrogen (A31572) 
 
3.2.5 X-gal staining 
 
Material Provider 
5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (x-gal) 
Roche Diagnostics Corporation, 
Indianapolis, IN, USA 
Dimethylformamide (DMF) Sigma-Aldrich, St. Louis, MO, USA 
Magnesium Chloride (MgCl2)  Sigma-Aldrich, St. Louis, MO, USA 
ethylene glycol tetraacetic acid 
(EGTA) 
Sigma-Aldrich, St. Louis, MO, USA 
Na deoxychalate  Sigma-Aldrich, St. Louis, MO, USA 
Kalium hexacyanoferrate II &III Sigma-Aldrich, St. Louis, MO, USA 
Igelpal CA-630  Sigma-Aldrich, St. Louis, MO, USA 
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3.2.6 X-gal staining buffer 
 
Buffer A Buffer B Buffer C 
100 mM PBS (pH 7.4) 100 mM PBS (pH 7.4) 5 mM  
2 mM MgCl2 2 mM MgCl2 5 mM 
5 mM EGTA 0.01% Na deoxycholate 1 mg/ml X-gal in DMF 
 0.02% IGEPAL CA-630 In Buffer B 
 
3.2.7 Perfusion 
 
Material Provider 
Paraformaldehyde  Sigma-Aldrich, St. Louis, MO, USA & 
Merck, Darmstadt 
Phosphate Buffered Saline  Sigma-Aldrich, St. Louis, MO, USA 
Sucrose  Sigma-Aldrich, St. Louis, MO, USA 
Ethylenediaminetetraacetic acid 
(EDTA) 
Sigma-Aldrich, St. Louis, MO, USA 
NaOH  Sigma-Aldrich, St. Louis, MO, USA 
NaCL   B.Braun, Melsungen 
10% Ketamin  Medistar Arzneimittelvertrieb GmBH, 
Ascheberg 
Xylazin  bela-pharm, Vechta 
Xylavet  cp-pharma, Burgdorf 
Scissors  fine science tools, Heidelberg 
Granulated dry ice  Linde AG, Muenchen 
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3.3 Consumables 
 
Consumables Provider 
Falcon Tubes 15 & 50 ml ThermoFisher Scientific, Waltham, MA, 
USA 
Glass Ware  Simax, Sazava, Tschechische Republik 
&VWR, Darmstadt & Druan, Wertheim 
Gloves blue & white Ansell, Brüssel, Belgium & VWR, 
Darmstadt 
Tissues  Kimberly-Clark, Mainz & VWR, Darmstadt 
Pasteur Pipette  VWR, Darmstadt &  
Big pipettes (5 ml, 10 ml, 25 & 
50 ml) 
Biosphere/SARSTEDT, Nuernbrecht 
Pipette tips (2.5 µl, 20 µl, 200 µl 
& 1 ml) 
Biosphere/SARSTEDT, Nuernbrecht 
Needles  Henry Schein, Langen & B.Braun, 
Melsungen  
Small petri dish  ThermoFisher Scientific, Waltham, MA, 
USA 
Syringes  B.Braun, Melsungen 
Filters  ThermoFisher Scientific, Waltham, MA, 
USA 
Eppendorf tubes  Eppendorf, Hamburg 
Tail tubes  Simport, Beloeil QC, Canada 
PCR tubes+ caps  Brand, Wertheim 
pH Standards  Merck, Darmstadt 
Spatulas   VWR, Darmstadt 
Gasburner  Fischer Scientific GmBH, Nidderau 
 
Sectioning 
Material Provider 
Coverslips  Menzel, Braunschweig 
Slides  ThermoFisher Scientific, Waltham, MA, 
USA 
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3.4 Equipment 
 
Equipment Provider 
Cryostat  Leica Biosystems, Wetzlar 
ddH2O Filter Millipore 
Advantage  
Millipore, Billerica MA, USA 
PCR Machines/Thermocycler  Applied Biosystems, Darmstadt 
Mac   
pH Meter  Eutech Instruments, Landsmeer, 
Netherlands 
Windows PC  
-Pipett Boy Pipetus  Hirschmann Laborgeraete, Eberstadt 
-Zetrifuge: Table  
Sorvall RC6 plus 
Eppendorf, Hamburg),  
ThermoFisher Scientific, Waltham, MA, 
USA 
Gel Doc  Peqlab, Erlangen 
Gel Chambers  BioRad, Hercules CA 
Incubator 37ºC  ThermoFisher Scientific, Waltham, MA, 
USA  
Shaker 37ºC Infors HT, Einsbach 
Vacuum pump  Eppendorf, Hamburg 
Autoclave  Systec, Wettenberg 
Balances Sartorius, Goettingen 
Shaker  Stuart, Staffordshire, UK 
Heater  Heidolph Instruments, Schwabach 
Stirrer  Heidolph Instruments, Schwabach 
Fridge  Liebherr, Biberach an der Riss 
Freezer: 
 -80˚C  
  
-20˚C  
 
ThermoFisher Scientific, Waltham, MA, 
USA,  
Gram, Sarstedt & Liebherr, Biberach an der 
Riss 
Nanodrop  Peqlab, Erlangen 
Waterbath  GFLN, Burgwedel 
Quiacube  QIAGEN, Hilden 
 
3.5 Microscopes  
 
Microscope Provider 
LSM 510 Carl Zeiss, Wetzlar  
LSM 710 Carl Zeiss, Wetzlar 
Aperio Scanscope Fl Aperio (Leica), Wetzlar 
NIKON SMZ25 Nikon GmbH, Duesseldorf 
Two photon microscope Mai tai Newport-Spectra-Physics, Darmstadt 
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3.6 Software 
 
Software Provider 
Prism  Graphpad Software Inc., La Jolla, CA, USA 
Excel  Microsoft 
Word  Microsoft 
ZEN  Carl Zeiss GmBH, Jena 
Fiji  Open source software 
Matlab  Mathworks, Ismaning 
Scanscope Viewer  Leica Biosystems, Wetzlar 
Papers   Mekentosj B.V., Dordrecht, Netherlands 
 
3.7 Sequences 
 
3.7.1 Primers for vector construction 
 
Primer Name Length 
(bp) 
Sequence Type Annealing 
temp (ºC) 
Target 
OB1 35 TATATCCATGGATGGGCTGCCT
CGGCAACAGTAAGA 
f 67  NcoI site + caGS HA 
tag  
OB2 39 GCGCTTAATTAATTAGAGCAGC
TCGTATTGGCGGAGATG 
r 67 caGs stop codon 
(TAA) + PacI site 
OB3-F 26 CCATTGTGAAGCAGATGAGGAT
CCTG 
f 60 Internal caGs site 
OB4-R 22 CCCACAGAGCCTTGGCATGCT
C 
r 60 Internal caGs site 
OB5-F 27 GCCCAGTACTTCCTGGACAAGA
TTGAT 
f 60 Internal caGs site 
OB6-R 26 CATCTCCACTAGCAGTGCTGAT
TCTC 
r 60 Internal caGs site 
OB7-F 42 CGGCGCGCCGAATTCCCATGG
TTAATTAAGGCGCGCCGGTAC 
f  N/A pBSMK1-Forward: 
SacI-AscI-EcoRI-NcoI-
PacI-AscI-KpnI 
OB8-R 42 CGGCGCGCCTTAATTAACCATG
GGAATTCGGCGCGCCGAGCT 
r  N/A pBSMK1-Forward: 
SacI-AscI-EcoRI-NcoI-
PacI-AscI-KpnI 
OB9-F 28 CTTAATTAAAGGCCTGGCGCGC
CGGTAC 
f  N/A pBSMK2-Forward: 
SacI-PacI-StuI-AscI-
KpnI 
OB10-R 28 CGGCGCGCCAGGCCTTTAATTA
AGAGCT 
r  N/A pBSMK2-Reverse: 
SacI-PacI-StuI-AscI-
KpnI 
mk146 20 GTCGTGAAGGAAGCAGTTCC f  N/A erxternal IRES caGs 
mk147 20 CCTAAGCGTATTCAACAAGG f 58 external Ires caGs 
AscI-mk245r 39 TATATGGCGCGCCACATCAAAA
GACTTTTCTCCTCAGTG 
r 67 Reverse primer from 
stop codon TGA plus 3 
nucleotides (TGT) at 
3’UTR m71 
PacI-mk246f 39 GCGTTAATTAAGATCTTCCAGA
AGCAATGAGCTTCTCTG 
f 64 Forward primer for left 
arm m71 
AscI-MK248-F 44 GTATATGGCGCGCCAAATGCTG
ATCTTTCTTCATGTAAAAGTAAG 
f 66 right arm forward 
primer m71 
NotI-MK249-R 43 TATATATATGCGGCCGCTTCCC
ATCTCAATTCATGTCATCAAG 
r 66 right arm reverse 
primer m71 
MK254-F   CTGACAATGTGTAATAACACTC
ATGTG 
f 55 la upstream junction 
MK255-R 36 CTAGTCTCTAATATCTTCCTTAC
CATC 
r 55 la upstream junction 
MK256-R   CTTGCAGAGGTTATCATACAGG
TGTGC 
r 60 RA upstream junction 
MK257-F   CTATCGTCACCTGGAAACAGAC
CTCT 
f 60 RA downstream 
junction 
MK258-R   ATGGATATACTCCATCATGGCA
GGGAAG 
r 60 RA downstream 
junction 
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Primer Name Length 
(bp) 
Sequence Type Annealing 
temp (ºC) 
Target 
MK259-F    GCTCTCGGCGCTTCTGAGGAG
A 
f 60 Internal ACNF primer 
MK260-R   TATAAAGGGCGTCACTCAGCCA
GTTC 
r 60 Internal ACNF primer 
MK261-F   CAGATTACGTATATCCTGGCAG
CGATC 
f 60 Internal ACNF primer 
MK262-R    CCAGGTTCGTTCACTCATGGAA
AATAGC 
r 60 Internal ACNF primer 
T7 20 TAA TAC GAC TCA CTA TAG GG   48 pBluescript cloning site 
T3 20 ATT AAC CCT CAC TAA AGG GA   48 pBluescript cloning site 
SP6 19 GAT TTA GGT GAC ACT ATA G   45 pBluescript cloning site 
M13 18 TGT AAA ACG ACG GCC AGT f 48 pBluescript cloning site 
M13R 17 CAG GAA ACA GCT ATG AC r 45 pBluescript cloning site 
SPANPK-F 38 CTTAATTAAGGCGCGCCGCGG
CCGCGTTTAAACGGTAC 
f 71 linker LA RA 
construction: SacI-
PacI-AscI-NotI-PmeI-
KpnI 
SPANPK-R 38 CGTTTAAACGCGGCCGCGGCG
CGCCTTAATTAAGAGCT 
r 71 linker LA RA 
construction: SacI-
PacI-AscI-NotI-PmeI-
KpnI 
mk261 short   GATTACGTATATCCTGGCAG f 50 Internal ACNF primer 
pBSOB4 
forward 
  CTTAATTAACGGCCGCCGCGGT
CTAGAGGTAC 
f  N/A linker: SacI-PacI-EagI-
SacII-XbaI-kpnI 
pBSOB4 
reverse 
  CTCTAGACCGCGGCGGCCGTT
AATTAAGAGCT 
r  N/A linker: SacI-PacI-EagI-
SacII-XbaI-kpnI 
OB1-F 26 GCTGGAGTACAACTACATCAGC
CACA 
f 60 junction: CFP ACNF 
OB2-R 26 AGGATGATCTGGACGAAGAGC
ATCAG 
r 60 junction: CFP ACNF 
MK 91 27 GCA GCT GTG GGC TTG TTC 
TAT GGA TCC 
f 63 M71 junction 
MK 92 20 AT GGA GAG CAA TGA TTC 
CTG 
r 50 M71 Junction 
OB11F 26 CTCAAGCGTATTCAACAAGGGG
CTGA 
f 60 IRES 3' forward primer 
OB12R 26 CTTGCTCACGATCTTCTGGTCC
TCAT 
r 60 gapCFP 5' reverse 
primer 
OB13R 26 GTGCAGATGAACTTCAGGGTCA
GCTT 
r 60 gapCFP 5' reverse 
primer downsteam 
MK249a-R   TATATATATGCGGCCGCGCTGG
TAAAACTGGATGTCCACATGTA
G 
r  N/A right arm reverse 
primer m71 
MK249b-R   TATATATATGCGGCCGCCTGAA
ACATGAGTTTAGCCATCTG 
r  N/A right arm reverse 
primer m71 
MK249c-R   TATATATATGCGGCCGCCCATA
TGGAACCATAAGAGACTAAGG 
r  N/A right arm reverse 
primer m71 
AEPAa reverse   GGCGCGCCTTAATTAAGAATTC
GGCGCGCCA 
r  N/A linker TOPO cloning 
reverse for pOB8 
insert 
(AscI_EcoRI_PacI_As
cI) 
AEPAa   GGCGCGCCGAATTCTTAATTAA
GGCGCGCCA 
f  N/A linker TOPO cloning 
forward for pOB8 
insert 
(AscI_EcoRI_PacI_As
cI) 
NAEPAPme   CATCGGGCGCGCCGAATTCTTA
ATTAAGGCGCGCCGTTT 
f  N/A linker TOPO vector for 
pOB8 insert 
(NcoI_AscI_EcoRI_Pa
cI_AscI_PmeI) 
NAEPAPme 
reverse 
  AAACGGCGCGCCTTAATTAAGA
ATTCGGCGCGCCC 
r  N/A linker TOPO vector for 
pOB8 insert 
(NcoI_AscI_EcoRI_Pa
cI_AscI_PmeI) 
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3.7.2 Genotyping primers 
 
Primer Name 
Internal 
number Sequence 
Length 
(bp) 
720 35 GCC CAC TTG ATT CCC TGA 18 
797 38 TGG AGC CCG TCA GTA TCG GC 20 
803 39 GCA GGC CTT CTC CAC CTG TGC TTC 24 
806 40 GCA GGC CTG ACA GAA AAA TAA AGG ATT C 28 
819 41 GAG AAG CGC GAT CAC ATG GTC CT 23 
824 42 ACA  TAC  TTC  CGG  CCA  CGC  TCA    21 
950 45 CAG TAA TAA GAC CAC AAA TGC CT 23 
1040 46 GCG AAT TCA AAG GCA AAG AAA TAT AGA AG 29 
1243 50 AGC CAC TTG GAG AAT TCA TTG 21 
1571 54 TTG CAG GGT GTA GTC CCC CTG AG 23 
1992 55 CCC AAA TTT TAT TTT CTG CCA TCA C 25 
1121B 47 GCA GCT GTG GGC TTG TTC TAT GGA TCC 27 
1257A 52 GAA GAG TGC CCT CAG CAG GAC C 22 
721A 36 AAA GGC CTC TAC AGT CTA TAG 21 
900A 43 TCC AAT TTA CTG ACC GTA CA 20 
901A 44 TCC TGG CAG CGA TCG CTA TT 20 
A114A 56 ATG GAG AGC AAT GAT TCC TG 20 
AW28 28 GCA TTG TAT GAG GTG GAC 18 
AW29 29 GAA ACA GAG CAG CTT TCA CCA 21 
Cat33 63 GAA CCC TGT TGT CTA CAG CCT CAG G 25 
Cre-R  388 TGTCCCTGAACATGTCCATCAG  22 
CZ40 64 GAA GCA GGA TGG TGA GAA GCT 21 
CZ40A 65 CTG CAG TTC GAT CAC TGG AAC 21 
G15A 68 TCC CGG GTG ATG GGT GAT GTT 21 
G3A 67 AAG AAG GCC TTC TCC ACC TG 20 
IRES-F  387 CGGTGCACATGCTTTACATGTG  22 
LL1294  252 ATG GGG AGA GTG AAG CAG AA 20 
LL1491  248 TTC CCA ACT GCC TGA GTC TT 20 
LL1492  250 CAC CAC CCG TAC CCA CTA C 19 
LL624 251 TAC GGG GTC ATT AGT TCA TAG  21 
M168 80 TCA CTG GGG CTT CCT ATA TGG 24 
M169 81 CAA GTT TTA TAT TAT CAA CTG CTC C 25 
MK162 153 GTG ATG AAG ATC CGC TCT GTG GAG 24 
MK163 154 CTG TTA CCT GTG GTC CAC AGT CGT A 25 
MK564 221 AGG TTA GGC TTC AGG CCA AT 20 
MK565 222 GGT ACC CTG  GGT TTT CGA TT 20 
MK99 151 GAG AAG CGC GAT CAC ATG GTC CT 23 
olMR0042   385 CTAGGCCACAGAATTGAAAGATCT  24 
olMR0043   386 GTAGGTGGAAATTCTAGCATCATCC  25 
SF1 123 CTT GGT GCC TCT CAG CCT CAT CCT G 25 
SF2 124 CAG TCT TGC TGC AGC TCA AGC ATC C 25 
SF3 125 GAG AAG CGC GAT CAC ATG GTC CT 23 
SF7 129 CTC ATT GGT CTG TCA GTG G 19 
T334 91 TGA CGG CAG TTA TCT GGA AG  20 
T335 92 TAA CGC CTC GAA TCA GCA AC  23 
 37 
Primer Name 
Internal 
number Sequence 
Length 
(bp) 
T524 95 ACC TGG TAA GGT CAT TCC TGA GTG 24 
T525 96 ACA TCT CAG TAG CTT TAC CAC GAT 24 
 
3.7.3 Restriction enzyme sites  
 
Enzyme Restriction Site NEB Buffer 
AscI 5’…GG/CGCGCC…3’ 
3’…CCGCGC/GG…5’ 
CutSmart 
EagI 5’…C/GGCCG…3’ 
3’…GCCGG/C…5’ 
3.1 
EcoRI 5’…G/AATTC…3’ 
3’…CTTAA/G…5’ 
Unique 
HindIII 5’…A/AGCTT…3’ 
3’…TTCGA/A…5’ 
2.1 
KpnI 5’…GGTAC/C…3’ 
3’…C/CATGG…5’ 
1.1 
NcoI 5’…C/CATGG…3’ 
3’…GGTAC/C…5’ 
3.1 
NotI 5’…GC/GGCCGC…3’ 
3’…CGCCGG/CG…5’ 
3.1 
PacI 5’…TTAAT/TAA…3’ 
3’…AAT/TAATT…5’ 
CutSmart 
PmeI 5’…GTTT/AAAC…3’ 
3’…CAAA/TTTG…5’ 
CutSmart 
SacI 5’…GAGCT/C…3’ 
3’…C/TCGAG…5’ 
1.1 
SacI-HF 5’…GAGCT/C…3’ 
3’…C/TCGAG…5’ 
CutSmart 
SacII 5’…CCGC/GG…3’ 
3’…GG/CGCC…5’ 
CutSmart 
XbaI 5’…T/CTAGA…3’ 
3’…AGATC/T…5’ 
CutSmart 
XhoI 5’…C/TCGAG…3’ 
3’…GAGCT/C…5’ 
CutSmart 
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4 Methods 
 
4.1 Molecular work 
 
This chapter describes the methods used for molecular work, the 
modification of the deoxyribonucleic acid (DNA), the generation of new 
plasmids and the amplification of DNA regions of interest. 
 
4.1.1 Polymerase chain reaction (PCR) 
 
In the thermocycler the hydrogen bonds of the double-stranded DNA are 
broken, the primers anneal at the complementary position and Taq DNA 
polymerase uses these primers as starting points to complement the single 
DNA stands to double strands again. This process is repeated for several 
cycles while the original DNA and the new synthetized strands serve as 
template for DNA synthesis, doubling the DNA sequence defined by the 
primers in each cycle. 
PCR was performed to genotype the strains using the protocols described 
in Chapter 4.8.2 using the standard protocols there. Also PCR was used to 
generate PCR fragments for targeting vector construction as described in 
Chapter 4.1.8. 
 
4.1.2 Gel electrophoresis  
 
Gel electrophoresis is a method to separate DNA molecules by their size. 
To that end, the DNA molecules, mostly from PCR reactions or restricted 
plasmids, are loaded with the loading dye onto agarose gels with 3 µl 
Ethidium Bromide (EtBr) per 100 ml gel. EtBr intercalates with double-
stranded DNA and shows fluorescence in the UV spectrum (302 nm). The 
percentage of agarose varies for the different experiments and ranges from 1 
to 1.5 % (w/v). After applying a voltage, normally between 80 to 120 V, the 
negatively charged DNA molecules migrate toward the positive pole. Due to 
the interconnections that the agarose forms after heating, larger molecules 
are traveling slower through the gel. A standard with known DNA sizes is 
loaded onto the gel for reference.  
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4.1.3 Restriction enzyme digestion 
 
To generate the plasmids described in Chapter 5 and to arrange the DNA 
sequences restriction endonucleases were used. These enzymes recognize 
specific sequences of four to eight base pairs of DNA and cleave after a 
specific nucleotide of that sequence. All endonucleases and buffers were 
obtained from New England Biolabs (NEB). Occasionally the restricted DNA 
molecule is additionally treated with CIP to remove phosphate from restriction 
sites and prevent reannealing. The restriction reaction (Table 4.1) is incubated 
at 37ºC for 4 h or overnight. If necessary, the sample is incubated with 1 µl of 
CIP at 37ºC for 10 min afterwards. The mix is loaded on a 1% ultrapure 
agarose gel and run with 80 V. The DNA is cut from the gel and purified using 
Qiagen Gel Extraction Kit.  
 
Table 4.1 Restriction mixture 
 µl 
DNA (5 µg or 10 µg) X 
Buffer  2  
BSA (depending of enzyme) 0.2 
H2O Fill up to 19 (18 if double digestion) 
Enzyme(s) 1 
Total 20 
 
4.1.4 Ligation 
 
To insert the restricted and cleaned DNA fragments into a plasmid vector a 
ligation reaction is set up. For each insert and vector several concentrations 
for the insert are tested. The mixture is incubated at 4ºC overnight or at 16ºC 
for 5 h. The ligated mixture is used for transformation. The ligation kits used 
were from TaKaRa (Shiga, Japan) for ligation of long fragments or from 
Promega (Madison, WI, USA) for assembling the insert cassette. 
 
Table 4.2 Ligation mixture 
 
 
 µl µl µl µl 
Vector 1 1 1 1 
Insert 1.5 5 9 0 
Buffer 2 2 2 2 
Ligase 1 1 1 1 
Water 14.5 11 7 16 
Total volume 20 20 20 20 
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4.1.5 Transformation 
 
This protocol was used to transform the bacteria with the plasmid 
generated for this thesis. Using bacteria culture is a fast way to amplify 
plasmids for further usage, using the antibiotic resistance provided by the 
plasmid to foster the growth of the transformed culture.    
 
• Remove required number of LB-Carb plates from 4°C and warm in 37°C 
incubator. 
• Leave open for 10-15 min to dry the plates (not too dry!) 
• Thaw competent cells on ice slowly, over 5-10 min. 
• Label Eppendorf tubes and place them on ice. 
• Dispense 50 µl of competent cells to labelled Eppendorf tubes gently. 
• Add 3 µl ligation reaction mixture (see Ligation protocol). 
• Incubate the cells-ligation mixture on ice for 30 min. 
• Heat shock cells for 45 sec at 42°C in the water bath. 
• Place tubes immediately on ice. 
• Leave the cells to rest for 10 min. 
• Add 500 µl SOC medium to each tube (Always 10x of the competent cell 
volume) and leave for another 10 min on ice. 
• Incubate on rotating platform for two hours at 37°C. 
• Add 20 µl of X-Gal directly onto plate and spread evenly with plastic 
spreads. (Only necessary for first insert) 
• Put plates back in 37°C incubator and leave the plates exposed to dry for 
10-30 min. 
• Remove the competent cells from rotating platform and begin spreading. 
• Resuspend the cells gently by pipetting and transfer 300 µl directly onto 
plate. 
• Spread gently and evenly with glass pipettes.  
• Incubate plates at 37°C overnight. Remove the plates to RT or 4°C in the 
morning. 
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4.1.6 DNA extraction from colonies 
 
This chapter describes the protocols used to seed a culture with the 
transformed bacteria and to extract the plasmid from it after growth. Two sizes 
of cultures were used: a 20 ml (mini) and a 200 ml (midi). The 20 ml culture is 
used to verify the correct sequence of the plasmid and the 200 ml is used to 
obtain larger volume of plasmid vector for further processing. To extract the 
plasmid from the cultures the Qiagen Kits for Mini and Midi Prep are used. For 
Mini Prep the extraction is done both manually as well as using the Qiacube. 
 
Colonies are picked from agar plates with sterile pipette tips. The tip is then 
inserted in LB medium with Carbenicillin with final concentration of 50 µg/ml. 
The seeded culture is kept overnight (16-20 h) at 37ºC and 150 rpm. When 
the bacteria culture is grown overnight the plasmids are extracted using the 
protocols provided by the Qiagen kits.  
 
Following either protocol the cultures are spun down in a centrifuge and the 
supernatant is removed leaving the bacteria pellet behind. Subsequently, 
buffers and filter syringes provided in the kit are used to break the cells open 
and filter out all other molecules and organelles. The plasmids are then 
cleaned with ethanol and suspended in TE buffer for storage. 
 
4.1.7 Sequencing 
 
To verify the success of a ligation after preliminary testing with PCR or 
restriction enzyme digestion, plasmids are sequenced with corresponding 
primers. Targeted sequences are amplified similar to a PCR. However a 
proportion of the nucleotides used for sequencing is labeled and terminates 
the annealing reaction. Each of the four nucleotides is labeled differently. By 
measuring the length of the terminated fragment and knowing the label for 
each nucleotide the sequence of the template can be determined. The 
sequencing service of Qiagen (Hilden) was used. Sequencing results were 
generated as digital files.  
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4.1.8 Generating gene-targeting vectors 
 
To generate the gene-targeting vectors for Chapter 5 multiple restrictions 
and ligations were needed using the techniques described in this chapter. The 
flowcharts illustrate the steps taken for generation of the final targeting vector.  
 
For the insertion cassette a polylinker of nucleotides was generated 
containing SacI, AscI, EcoRI, NcoI, PacI AscI and KpnI as restriction sites 
(ThermoFisher). This linker was inserted in pBluescript K+ Vector (Agilent 
Technologies). Afterwards the other sequences were ligated into the vector 
(Figure 4.1) step by step. The caGs (constitutively active G-protein subunit s) 
sequences were obtained from T. Imai (Imai et al., 2006) and amplified from 
the donated vector with primers designed to flank the gene by restriction sites 
for NcoI and PacI. All other sequences were taken from stock plasmids 
available in the lab. The sequences were cut from the vector with restriction 
endonucleases (see Chapter 3.7.3), cut from gel and ligated in the target 
vector restricted with the same enzymes. Afterwards bacteria were 
transformed (see Chapter 4.1.5) with the ligated vector. After testing the 
correct insertion and transformation with PCR and sequencing the bacteria 
were amplified in a midi approach (see Chapter 4.1.6) and the plasmid vector 
was extracted and the process was repeated for the next step. 
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Figure 4.1 Generating the insertion cassette vector 
In this figure the individual steps of restriction reactions and ligation constructing the insertion cassette 
vector are shown. The line represents the part of the plasmid vector containing the linker with all the 
restriction sites needed for the construction. Each insert was cut from the origin plasmid and ligated in 
the insertion cassette vector, except caGs, which was amplified from the original plasmid by PCR 
adding the necessary restriction sites (indicated by the arrow symbols in step 2).   
 
 
At the same time the targeting vector on the basis of a pGEMT vector 
(Promega) was generated (Figure 4.2) by amplifying 4,532 base pairs (bp) in 
upstream direction from the end of M71 locus, called the left arm (la). Another 
arm was generated by amplifying 3,807 bp downstream of the M71 gene. 
Both PCRs used the Phusion Polymerase (Finnzyme through ThermoFisher) 
and were conducted with a M71 targeting available available in the lab. These 
two arms were inserted in the targeting vector and as a final step the insertion 
cassette generated in the other vector was cut and ligated in the targeting 
vector. The PmeI restriction site in the targeting vector is used for linearization 
of the vector prior to electroporation into ES cells.  
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Figure 4.2 Generation of the gene-targeting vector 
In this figure the individual steps of restriction reactions and ligation constructing the targeting vector are 
shown. The line represents the part of the plasmid vector containing the linker with all the restriction 
sites needed for the construction. The left and right arms of the targeting sequence were amplified for 
the M71 targeting vector with PCR adding the necessary restriction sites (indicated by the arrows). As a 
final step the insertion cassette was ligated into the targeting vector.  
 
 
For a new construct the IRES-tauGFP sequences were replaced with IRES-
tauCFP sequences but using the same method and concept. 
 
4.2 Perfusion & Cryoprotection 
 
Fixation of tissue is the first and most critical factor in microscopy. A strong 
fixation might prevent antibodies from reaching the intended targets and a 
weak fixation will not stop the degradation of the tissue post mortem. Likewise 
a good cryoprotection prevents tissue damage and preserves the anatomical 
structure of the tissue. The following protocol details the methods found most 
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suitable for the experiments in the mouse olfactory system reported in this 
thesis. 
Mice were anesthetized with an intraperitoneal (i.p.) injection of 0.01ml/g 
anesthetic (0.25 ml 2% Rompun, 1.2 ml 10% Ketamin and 8.55 ml 0.9% 
NaCl) and after onset of narcosis fixed on a bench. Alcopads were used to 
mildly sterilize the fur and the skin was removed from the mouse abdomen. 
The ribcage was removed from sternum to throat. The left ventricle of the 
heart was pierced at the apex, parallel with the heart, with the syringe 
containing 1x PBS, then the right atrium was opened and the PBS was 
pumped into the ventricle. For PD21 or younger mice, 10 ml of PBS was used 
to wash out the blood. For PD70 mice 20 ml was used. Following the 
perfusion with PBS the mouse was perfused with the same volume of 4% 
PFA in 1x PBS (10 ml for PD21 mice).  
 
 
Figure 4.3 Perfusion  
Image of perfusion of a PD21 mouse. A needle is inserted in the left ventricle. The arrowhead points to 
right atrium. 
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After perfusion the head was removed with scissors. The mouse was tailed 
for genotyping. The skin, as well as eyes, ears, lower jaw and the palatine 
bone were removed. The head was immersed in 4% PFA in 1x PBS for 5 min 
in a vacuum pump and then incubated at 4ºC for 2 h on a shaker. After the 
incubation PFA was exchanged for 0.45 M EDTA in 1x PBS and incubated 
over night on a shaker at 4ºC (two nights for PD70 mice). EDTA was 
exchanged for 15% sucrose in 1x PBS and consecutively 30% sucrose in 1x 
PBS, always incubated over night at 4ºC on a shaker (time doubled for PD70 
mice).  
 
After cryoprotection the head was trimmed and the teeth were removed. 
The caudal part of the head was cut in coronal direction (frontal plane) so it 
could be placed on the stage of the microtome for freezing. Afterwards the 
head was immersed in a cylinder of aluminum foil filled with O.C.T. The rostral 
tip was orientated to point to the center of the cylinder and the coronal base of 
the head was lowered to the bottom. Afterwards the cylinder was placed in 
granulated dry ice until O.C.T. was frozen. The cylinder with the frozen block 
was stored at -20ºC for sectioning.  
 
4.3 Sectioning 
 
A consistent and reproducible method for sectioning is crucial for cell 
counts and reconstructions of three-dimensional objects from sections. All 
sections were collected from the fixed and frozen mice heads gained with the 
previously detailed method. The frozen samples were sectioned with a Leica 
CM3050 S cryostat at 12 µm thickness and -20ºC. The sections were 
collected in sets of ten slides, alternating the slides for each section. In the 
end each slide contained 12 sections. The whole epithelium was sectioned in 
this manner and collected in sets of ten slides. The slides were stored at 4ºC 
up to 48 h or at -80ºC for longer storage. 
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4.4 Whole mount dissection (sagittal & dorsal) 
 
While sections are ideal for the analysis of the cellular composition and 
quanititative estimates, whole mount preparations of the olfactory system are 
important for a general overview of the axon projections of the OB. Two 
different directions of the sections for the whole mounts were used: sagittal 
and dorsal. Each direction enables a different view on the OB and in concert 
they provide an overview of the axon projections for the strains reported in 
this thesis. 
Mice were anesthetized with an i.p. injection of 0.01 ml/g anesthetic (0.25 
ml 2% Rompun, 1.2 ml 10% Ketamin and 8.55 ml 0.9% NaCl). After onset of 
narcosis the mouse was decapitated with scissors. The mouse was tailed for 
genotyping. The skin, eyes, ears, lower jaw and the palatine bone were 
removed.  
For the sagittal whole mount preparation the septum was cut from the 
ventral side with a scalpel and then the rest from the dorsal side. The halfs 
were separated and the rest of the septum was removed. 
For the dorsal whole mount preparation the skull was cut along the midline 
of the axial plane from the cauda over the ear holes to the eye sockets. Then 
the dorsal part was carefully removed with a forceps. 
The heads were stored in 1x PBS at 4ºC. 
 
4.5 β-galactosidase staining 
 
Some of the strains used express not a fluorescent reporter but β-
galactosidase (β-gal). While fluorescent cells can be visualized directly with 
the microscope, β-gal tissue has to be stained and can only be observed 
afterwards with a bright field microscope. However, the reaction product is 
more stable. The protocol described in the following was used for visualization 
of OSNs expressing β-gal. 
Sagittally or dorsally dissected samples were fixed with 4% PFA in 1x PBS 
for 10 min at 4ºC. The PFA was removed and the samples were washed once 
with Buffer A at 4ºC and then washed twice with Buffer A (Chapter 3.2.6) at 
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room temperature (RT) each for 5 min. Then the samples were incubated at 
RT in Buffer A on a shaker for 5 min. Afterwards the samples were incubated 
twice at RT in Buffer B for 5 min each. The samples were afterwards inserted 
into Buffer C and incubated for an hour or overnight at 37ºC in the dark until a 
strong blue staining was visible. The samples were then washed in Buffer B 
and stored in 4% PFA in 1x PBS. 
 
4.6 Fluorescent antibody staining 
 
For antibody staining two different protocols were used. One protocol is 
optimized for the Neuropilin-1 antibody and one for all other antibodies used.  
 
4.6.1 Neuropilin-1 protocol 
 
• Drying sample slides from -80ºC or 4ºC with dryer (cold wind). 
• Wash three times in 1x PBS at RT for 5 min each 
• Blocking with 10% NDS in 1x PBS / 0.1 % Triton X 100 (PBS-T), 150µl 
per slide, cover with parafilm strip and incubation at RT for 1 h 
• Remove excess blocking solution 
• Primary antibody Goat α Nrp1 (1:100) (optional add Rabbit α dsRed 
1:200 for double staining) and 3% BSA in PBS-T, 150 µl per slide, 
cover with parafilm strip and incubate over night (>16 h) at 4ºC  
• Wash three times in PBS-T at RT for 10 min each 
• Secondary antibody Donkey α Goat Cy5 (1:250) (optional add Donkey 
α Rabbit Alexa 555 1:250 for double staining) and 3% BSA in PBS-T, 
150 µl per slide, cover with parafilm strip and incubate for 1.5 h at RT  
• Wash three times in PBS-T at RT for 10 min each 
• Wash once PBS for 1 min at RT 
• DAPI staining with 5 µl of 5 mg/ml DAPI stock solution to 150 ml PBS 
for 10 min at RT 
• Wash the slides with PBS 
• Mount slides with 60 µl Moviol and coverslip 
• Let slides dry over night at RT 
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4.6.2 β-galactosidase staining protocol 
 
• Drying sample slides from -80ºC or 4ºC with dryer (cold wind). 
• Wash three times in 1x T-PBS at RT for 10 min each 
• Blocking with 10% NDS in PBS-T, 150 µl per slide, cover with parafilm 
strip and incubation at RT for 1h 
• Remove excess blocking solution 
• Primary antibody Chicken α LacZ (1:500) and 2% NDS in PBS-T, 150 
µl per slide, cover with parafilm strip and incubate over night (>16h) at 
4ºC  
• Wash three times in PBS-T at RT for 10 min 
• Secondary antibody Donkey α Chicken FITC (1:250) and 2% NDS in 
PBS-T, 150 µl per slide, cover with parafilm strip and incubate for 1h at 
RT  
• Wash three times in PBS at RT for 10 min 
• DAPI staining with 5 µl of 5 mg/ml DAPI stock solution to 150 ml PBS 
for 10 min at RT 
• Wash the slides with PBS 
• Mount slides with 60 µl Moviol and coverslip 
• Let slides dry over night at RT 
 
4.7 Microscopy 
 
Confocal imaging was performed using Zeiss LSM 510 and 710. For cell 
counting 25x water immersion lens and for glomerular volume measurements 
40x water immersion lens was used. For confocal whole mount images 10x 
water immersion and 5x air lens were used. Whole slide scanning for 
overviews was performed with Aperio scanscope FL. Whole mount two 
photon images were taken with 40x water immersion lens using the Mai Tai 
system. Fluorescent whole mount images were also done using the NIKON 
SMZ25 stereomicroscope.   
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4.8 Genotyping 
 
4.8.1 Genomic DNA extraction 
 
 
This method was used to extract genomic DNA from tail biopsies. The tails 
were usually obtained while weaning the mice at PD21 and after perfusion for 
confirmation. Approximately 5 mm of tail was cut and placed in screw capped 
tail tubes. The tail biopsy was kept at -20ºC until lysis. Before genotyping the 
tail was incubated overnight at 55ºC in 200 µl of 1:100 Proteinase K (20 
mg/ml) in digestion buffer. The next day Proteinase K was deactivated at 
85ºC for 45 min. The tail lysate was stored at 4ºC until genotyping.  
 
4.8.2 Genotyping protocols   
 
 
For this thesis it was of great importance to determine unambiguously the 
genotype of the mice used. Especially for the complex breeding described in 
Chapter 7, reliable and accurate genotyping was essential. To achieve a high 
level of certainty, specific primers for each gene-targeted strain and crosses 
were used to amplify specific DNA sequences of known length using PCR. 
The table below details the primer pairs used and the PCR program chosen 
for each strain (Table 4.3). For most strains a primer pair for the wild type 
(WT) allele and the mutated (MUT) allele was tested. This was not possible 
for transgene (TG) strains since the locus in the genome is unknown. For 
each genotyping positive (B6), negative (water) were tested as well. 
	  
Table 4.3 List of primers for genotyping 
 
Mutant name Oligo wildtype 
WT band 
size Oligo MUT 
MUT band 
size PCR 
M71-IRES-tauGFP 1121B/A114A 309 bp 819/ A114A ~250 bp PCR 1 
M71-IRES-taulacZ 1121B/ A114A 309 bp 797/ A114A ~250 bp PCR 1 
M71-IRES-tauRFP2  1121B/ A114A 309 bp SF5/A114A 701/1397 bp PCR 1 
M71-IRES-tauYFP 1121B/ A114A 309 bp 819/ A114A ~250 bp PCR 1 
M71-IRES-Cre 1121B/ A114A 309 bp 900A/ 901A ~450 bp PCR 1 
RFP->M71-IRES-M71-IRES-
tauGFP 
1121B/ A114A 309 bp 819/ A114A ~300 bp PCR 1 
b2AR->M71-IRES-tauGFP 1121B/ A114A 309 bp 819/ A114A ~300 bp PCR 1 
b2AR->M71-IRES-taulacZ 1121B/ A114A 309 bp 797/ A114A ~250 bp PCR 1 
          
MOR23-IRES-tauGFP Cat33/ 1992 243 bp 819/ 1992 ~300 bp PCR 1 
MOR256-17-IRES-tauGFP  MK162/ MK163 455 bp MK99/ MK163 401 bp PCR 1 
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Mutant name Oligo wildtype 
WT band 
size Oligo MUT 
MUT band 
size PCR 
M50-IRES-GFP-IRES-taulacZ 803/ 806 404 bp 797/ 806 ~300 bp PCR 1 
mOR37C-IRES-tauGFP G3A/ G15A ~400 bp 819/ G15A ~300 bp PCR 1 
S50-IRES-tauGFP T524/ T525 586b p 819/ T525 ~750 bp PCR 7 
mI7-IRES-tauGFP M168/ M169 361 bp 819/ M169 ~250 bp PCR 7 
SR1-IRES-tauGFP SF1/SF2 562 bp SF3/ SF2 439 bp PCR 1 
P2-IRES-tauGFP 824/ 1243 220 bp 819/ 1243 ~213 bp PCR 1 
P3-IRES-tauGFP 1257A/ 1040 198 bp 819/ 1040 ~300 bp PCR 1 
M72-IRES-tauGFP 1121B/ 950 475 bp 819/950 ~400 bp PCR 1 
      
Neuropilin-1-floxed    
 
~200 bp AW28/ AW29   ~350 bp PCR 1 
npn1-5247/J ~ 550 bp MK564 / 
MK565 
660 bp, 710 
bp 
PCR 1 
I7(WT)-Cre 
oIMR0042/oIMR
0043 
324 bp IRES-F / Cre-
R 
260 bp PCR 1 
OMP-Cre CZ40A/ 721A 542 bp 900A/ 901A ~450 bp PCR 1 
OMP-tau-STOP-lacZ CZ40/ 721A 615 bp 1571/ 720 ~200 bp PCR 7 
ROSA-STOP-taulacZ   T334/ T335 488 bp PCR 1 
Z/EG LL1491/ LL1492 588 bp LL624/ 
LL1294 
~400 bp PCR 1 
 
For all genotyping reactions a standard reaction mix was used. For each 
reaction 0.40 ml of each primer at 20 µM concentration was used. Buffer, 
dNTPs and Taq were provided by Takara Bio Inc. 
 
Table 4.4 Reaction mix 
 µl 
H2O 18.08  
10 x Puffer 2.50  
dNTP 2.00  
Each primer 0.40  
Taq 0.12  
Template 1.50  
Total 25.00  
 
 
For genotyping two protocols for PCR were used, internally called PCR 1 
and PCR 7. Otherwise the PCR did not differ from the method described in 
4.1.1. 
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Table 4.5 PCR protocols for genotyping 
Steps PCR1 Cycles (35x) PCR 7 Cycles (40x) 
Initial denaturation 95ºC 5 min 94ºC 5 min 
DNA denaturation 95ºC 1 min 
1 min 
2 min 
94ºC 45 sec 
30 sec 
1 min 
 60ºC 58ºC 
DNA polymerization 72ºC 72ºC 
Final polymerization 72ºC 10 min 72ºC 10 min 
Holding 4ºC  4ºC  
 
After PCR amplification the DNA fragments were stained with loading dye 
and loaded on a 1,5% agarose in TBE gel and the NEB standard was added. 
The gel was run at 120V in TBE buffer for approximately 30 min. Gel pictures 
were taken with PeqLab Geldoc. 
 
4.9 Cell counting 
 
Every fluorescent cell body profile with full nucleus in each section of PD21 
or younger mice was counted using a Zeiss confocal microscope LSM 510. 
Each section was counted manually, by direct inspection with the microscope. 
Sampling methods (Geuna, 2000; Guillery, 2002; Schmitz and Hof, 2005) 
were not used due to the multitude of distinct spatial expression patterns 
attributed to zones for OR genes. The sparse and possibly non-homogeneous 
distribution of OSNs that express a given OR gene make most techniques not 
practical. Due to the inherently strong tissue shrinkage in cryosections 
combined with the sparse distribution of labeled cells an optical dissector 
correction for the z-axis was not used (Benes and Lange, 2001). Instead an 
empirical strategy was chosen. Counting of up to ~50,000 cells in a mouse is 
still practical. To get a closer approximation to the real cell numbers the 
Abercrombie correction (Abercrombie, 1948) was applied to the cell counts. 
For the correction the average nucleus diameter of 10 cells for each of the 11 
core strains for Chapter 6 was measured (Figure 4.4). Subsequently for each 
strain the correction factor was calculated  (section thickness of 12 µm) using 
the formula (Table 4.6): 
 !"##  !"#$%& = !"##  !"#$%  ! !"#$%&'  !!!"#$%&&!"#$%"&  !"#$%&%'!!"#$%&'  !!!"#$%&& (!"##$!%&"'  !"#$%&). 
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Table 4.6 Nucleus diameter and correction factor 
Strain name Abbreviation Nuclear diameter (µm) 
Standard deviation 
(±µm)  Correction  
P3-IRES-tauGFP P3 4.51 0.80 0.73 
M71-IRES-tauGFP M71 4.26 1.05 0.74 
mOR37C-IRES-tauGFP mOR37C 4.39 0.62 0.73 
S50-IRES-tauGFP S50 4.40 0.91 0.73 
MOR23-IRES-tauGFP MOR23 4.00 0.39 0.75 
M72-IRES-tauGFP M72 4.47 0.74 0.73 
M50-IRES-GFP-IRES-taulacZ M50 4.49 0.79 0.73 
mI7-IRES-tauGFP mI7 4.53 0.65 0.73 
P2-IRES-tauGFP P2 4.53 0.60 0.73 
SR1-IRES-tauGFP SR1 4.49 0.72 0.73 
MOR256-17-IRES-tauGFP MOR256-17 4.59 0.58 0.72 
β2AR➝M71-IRES-tauGFP  4.26 1.05 0.74 
RFP➝M71iM71iGFP  4.26 1.05 0.74 
M71-IRES-tauYFP  4.26 1.05 0.74 
M71-IRES-tauRFP2  4.26 1.05 0.74 
 
A priori knowledge or assumptions of OSN distribution in the MOE are not 
needed, hence this strategy enables analysis and comparison of a relatively 
large number of strains.  
 
For overview images of the MOE, a Leica Aperio Scanscope FL was used. 
For mice older than PD21, cells in every fifth coronal section were counted. 
For statistical analyses and graphs, Graphpad Prism 5 was used. 
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Figure 4.4 Average nucleus diameter 
This figure shows the average nucleus diameter measured for 11 gene-targeted strains. Each symbol 
represents a single OSN measured. For each strain, 10 different OSNs were measured. There is no 
statistical significant difference between the diameters (One-way Annova, F=0.52, P=0.87). 
 
 
4.10 Glomerular reconstruction 
 
The same series of coronal sections used for estimating the OSN numbers 
were also used to determine the total glomerular volume (TGV) of fluorescent 
glomeruli in mice at PD21. Images of glomerular sections were taken with the 
LSM 510. Glomerular reconstruction and fluorescent pixel density 
measurements in glomeruli were performed using Microsoft Excel, Fiji V1.48u 
and Matlab V7.12. For statistical analyses and graphs, Graphpad Prism 5 was 
used. 
 
Glomeruli are distributed on average over five physical sections but can 
span more than ten physical sections. Glomeruli were not always of elliptical 
shape so a simple estimation for glomerular volume was not feasible 
(Schaefer et al., 2001).  
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First, glomeruli were reconstructed by taking z-stack images with the LSM 
510 in 1 µm intervals through all physical sections that contained labeled 
axons within the glomerular layer, similar to other methods reported 
(Cummings and Belluscio, 2010). In each optical section of the z-stack that 
contained a sharp and defined glomerular profile (Figure 4.5), the surface 
area of the glomerulus was measured. These areas were summed and 
multiplied with optical section thickness (1 µm) to get a close approximation of 
the glomerular volume. 
 
 
Figure 4.5 Measuring area in optical sections 
Confocal image of an M71-IRES-tauGFP glomerulus. Green, intrinsic fluorescence, white: DAPI. Scale 
bar: 20 µm. The area framed in magenta is measured as the cross sectional area of the glomerulus in 
this section. Image taken with a 40x lens. 
 
To reduce the labor of volume reconstruction, this thesis shows that a close 
approximation can be achieved by analyzing a single optical section per 
physical section. These optical section profiles from the middle of the physical 
section are summed and multiplied then with a factor of of 12 µm (the section 
thickness). The sum of all glomerular volumes of fluorescently labeled 
glomeruli per mouse is the TGV. This measure decreases the variance and 
corrects for differences in the numbers of glomeruli.  
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4.11 Measuring fluorescent pixel density  
 
 
Fluorescent pixel density of a glomerulus was calculated by using the 40x 
confocal images of the optical sections used for TGV reconstruction. Images 
were loaded into a Matlab program. The background fluorescence was 
defined for each image in labeled regions of the glomerular layer close to the 
labeled glomeruli, and a threshold was set at mean background pixel intensity 
of the image plus three times the mean backgrounds standard deviation. The 
area of fluorescence was measured manually as for the glomerular volume. 
All pixels above threshold in the glomerular area were measured, and the 
ratio to the entire glomerular area was calculated as the fluorescent pixel 
density. 
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5 Generating a gene-targeting vector for the M71 
locus 
 
5.1 Results 
 
Axonal wiring in the mouse olfactory system is a complex endeavor for the 
nascent OSN axon and still not fully understood. In 2006, Imai and colleagues 
(Imai et al., 2006) reported that a mutation in the G-protein binding site of the 
rat I7 OR (rI7) receptor abolishes axon wiring in OSNs expressing this 
receptor in transgenic mice. Axonal wiring can be recovered by expression of 
a constitutively active Gαs subunit (caGs). Expression of caGs in wild-type rI7 
expressing OSNs shifts the glomerular position more posteriorly. The model 
that has emerged form these results is that the basal level of cyclic adenosine 
monophosphate (cAMP) plays a crucial role in glomerular positioning along 
anterior-posterior axis. In the present study I tried to generate gene-targeted 
strains with a knockin of caGs in M71-expressing OSNs as opposed to the 
transgenic random integration approach by Imai and colleagues (2006).  
Unfortunately, the generation of a new gene-targeting vector needed to 
knockin caGs in the M71 locus failed despite of two approaches, which are 
described in the following paragraphs (5.1.1 and 5.1.2). 
 
The process of generating the gene-targeted strains starts with the cloning 
of the targeting vector. In short, a sequence fragment consisting of the desired 
mutation is designed to be flanked by ~5,000 bp arms that are homologous to 
the genome. The completed targeting vector is then linearized and 
electroporated in E14 embryonic stem cell lines. The correct clone with the 
mutation is then screened by Southern blot. The positively identified clone is 
afterwards microinjected in C57BL/6J blastocysts which are then transferred 
to pseudopregnant CD1 mothers. Among the resulting mice are chimeras, 
and male chimeras are bred with C57BL/6J females to generate F1 offspring. 
Germline transmission is often confirmed by coat color identification, followed 
by Southern blot analysis of the tail biopsies. 
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5.1.1 First strategy  
 
The cloning steps of the targeting vector for the M71 locus is described in 
Chapter 4.1.8. The cloning steps were based on modifying the existing 
targeting casettes for the M71 locus available in the lab. The task was to 
insert a new cassette “IRES-caGs” into an existing targeting vector, M71-
IRES-tauGFP thereby creating a tricistronic vector, M71-IRES-caGs-IRES-
tauGFP. Successful cloning steps were achieved resulting in the plasmid 
pOB08 (Figure 5.1A). Test restriction digest with three restriction 
endonuclease pairs (EcoRI/NcoI, NcoI/PacI & EcoRI/PacI, Figure 5.1B) 
showed the correct insertion and direction of the sequence (left example). 
Subsequently the correct plasmids were sent out to Qiagen for sequencing.  
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Figure 5.1 Generating gene-targeting vector 1  
(A) Vector map of the pOB08 vector. This was the last step (step 2, Figure 4.1), which gave 
positive results. Purple arrowheads represent primer binding sites for genotyping and 
sequencing. The arrow tip shows the direction of primer. Long arrows represent the insert, 
indicating the direction. Also shown are the restriction sites used in confirmation of targeting 
and as further insertion sites. (B) Gel electrophoresis of test restriction with three restriction 
endonuclease pairs (EcoRI/NcoI, NcoI/PacI, EcoRI/PacI) for two pOB08 plasmids (left and 
right lane). Expected bands additional to vector band (2000 - 3000 bp) are: EcoRI/NcoI 486 bp 
& 473 bp, NcoI/PacI 1185 bp, EcoRI/PacI 1050 bp & 757 bp. (C) Gel electrophoresis of PacI 
restriction for two clones of pOB08 (left lanes) and two IRES-tauGFP ACNF plasmids. The 
yellow box highlights the band excised as insert for step 3. 
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After the confirmation by sequencing the final step involved cloning the IRES-
tauGFP-ACNF cassette into pOB08 by PacI ligation (Figure 5.1C). However 
after several attempts using different clones of the IRES-tauGFP-ACNF 
plasmid and pOB08 forming the final plasmid pOB09 (Chapter 4.1.8) and 
despite intense screening and sequencing, a clone with the correct insert, 
which would have generated the full tricistronic construct, could not be 
identified. Different competent cell lines were used to facilitate correct plasmid 
amplification (dH5α, XL2-Blue Ultracompetent cells, MAX efficiency DH5a). 
 
5.1.2 Second Strategy 
 
Another approach was attempted; using another targeting vector donor 
available in the lab (IRES-gapCFP-ACNF) the fluorescent protein tauCFP was 
used as a reporter gene and with an additional linker the M71 targeting vector 
available in the lab was used (restriction endonuclease targeting site for PacI 
after M71 sequence). The assembly of the insert for the targeting vector 
worked and resulted in the plasmid pOB13 (IRES-caGS-IRES-gabCFP-ACNF, 
Figure 5.2A). Correct assembly was confirmed by PCR and restriction 
enzyme digest to identify correct clones (Figure 5.2B). However I encountered 
the same difficulty in the final ligation step to generate the tricistronic vector 
pOB13 (Figure 5.2C). After several attempts over months the project was 
finally suspended due to time constraints.  
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Figure 5.2 Generating gene-targeting vector 2 
(A) Vector map of the pOB13 vector. This was the last step, which gave positive results. Yellow 
arrowheads represent primer binding sites for genotyping and sequencing. The arrow tip shows the 
direction of primer. Long arrows represent the insert, indicating the direction. Also shown are the 
restriction sites used in confirmation of targeting and as further insertion sites. (B) Gel electrophoresis 
for PCR for primer pairs OB1/OB2 (700 bp) and 1295/M13R (280 bp) and test for linearization with PacI 
restriction for two samples of pOB13 targeting vector. Sample two is negative for correct inserts. (C) Gel 
electrophoresis of PacI restriction of pOB13 and M71 targeting vector. Yellow box indicates 7000 bp 
band excised for insertion in M71 targeting vector after gel extraction. 
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5.2  Discussion 
 
Unfortunately both strategies to generate a gene-targeting vector that 
expresses caGs and a fluorescent reporter gene from the M71 locus failed. 
There are several explanations why no correct and functional plasmid was 
obtained. One possibility is that the double IRES sites in the construct are 
toxic for the competent cells, or just very hard to correctly amplify due to the 
long GC rich sequence in IRES. It might be that the two IRES sequences 
interact because of the highly repetitive sequence homology and a 
recombination event occurs. In several sequencing results of the plasmids the 
sequence of the inserts seemed to be incorrect or not in the right orientation. 
Another problem might be the size of the vectors, which might influence the 
amplification of the plasmid. 
 
I initiated this project to test the hypothesis of a prevailing model that cAMP 
determines the positional axis of glomeruli. Although the final cloning steps 
failed, I have gained a lot of insights and experience in targeting vector 
construction. 
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6 Quantitative analysis of gene-targeted strains 
6.1 Results 
 
The chemosensory system in mouse relies on the expression of ~1,200 
OR genes across millions of OSNs for specificity. These millions of OSNs in 
the MOE project their axons to the OB and form ~3,600 glomeruli. In this 
chapter 17 gene-targeted strains are reported of the OR-IRES-marker design 
coexpressing a fluorescent protein or –taulacZ.  
Representing a 1% sample of the OR gene repertoire, 11 strains were 
selected for detailed analysis. All serial coronal sections were evaluated 
quantitatively using confocal microscopy - a total of 685,673 cells in 56 mice 
at postnatal day 21 were counted. A strain-specific Abercrombie correction to 
these OSN counts was applied, in order to obtain a closer approximate of the 
true OSN numbers. In the same series of coronal sections, the total volume of 
the glomeruli (TGV) formed by coalescence of the fluorescent axons was 
measured, finding a strong linear correlation between OSN number and TGV. 
This leads to the conclusion that the glomerular volume is a possible estimate 
for cell numbers.  
Most of these data have been published in Bressel et al. (2015). 
 
6.1.1  Cell counts 
 
The OSN numbers in the core set of 11 strains representing the 11 gene-
targeted OR genes after Abercrombie correction at PD21 are, from low to 
high: P3 (2,236 ± 247 cells), M71 (2,419 ± 484), mOR37C (2,660 ± 175), S50 
(3,289 ± 503), MOR23 (4,446 ± 327), M72 (5,265 ± 906), M50 (6,716 ± 648), 
mI7 (9,892 ± 1,852), P2 (13,975 ± 1,982), SR1 (23,846 ± 1,706), and 
MOR256-17 (37,023 ± 6,318) (Figure 6.1). The average OSN number has 
thus a range of 17-fold across these 11 OR-tagged strains. Importantly, the 
spread within a given OR-tagged strain is fairly small (see also below, 
coefficient of variation).  
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Figure 6.1 Numbers of fluorescent cells in OR-IRES-tauGFP strains 
Average OSN number of the core set of 11 gene-targeted strains at PD21. A symbol represents a single 
mouse. The blue line indicates the median of 5,983.  
 
The numbers of fluorescent cells in six other strains with mutations in the 
M71 gene are-: β2AR➝M71-IRES-tauGFP (460 ± 131), β2AR➝M71-IRES-
taulacZ (1475 ± 334), RFP➝M71iM71iGFP (650 ± 77), M71-IRES-tauYFP 
(1,558 ± 156), M71-IRES-tauRFP2 (1,893 ± 14) (Figure 6.2) and M71-IRES-
taulacZ (4610 ± 579). There is no significant difference (t-test, p = 0.21) in 
OSN numbers between M71-IRES-tauGFP and M71-IRES-tauRFP2 (red 
fluorescent protein), indicating a similar probability of OR gene choice and 
sensitivity of detection of intrinsic fluorescence. The OSN number in M71-
IRES-tauYFP mice (yellow fluorescent protein) is lower than in M71-IRES-
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tauGFP mice (t-test, p = 0.022) and M71-IRES-tauRFP2 mice (t-test, p = 
0.015), reflecting a possible difference in probability of OR gene choice and/or 
in sensitivity of detection of intrinsic fluorescence. OSN number is significantly 
higher in the strain expressing taulacZ as a reporter gene (t-test, p = 0.0003). 
OSN numbers are decreased in mutations in which the M71 coding region is 
replaced by that of the β2-adrenergic receptor (β2AR➝M71-IRES-tauGFP) (t-
test, p < 0.0001) and (β2AR➝M71-IRES-taulacZ) (t-test, p = 0.02) or in which 
M71 translation is decreased by an IRES-mediated knockdown (hypomorph, 
RFP➝M71iM71iGFP) (t-test, p = 0.0007).  
There are 2,067 ± 441 OSNs in M71-IRES-tauGFP mice (n=3) at PD70, 
which is not significantly different (t-test, p = 0.52) from PD21. For the 
hypomorph there is no difference either between PD21 and three mice at 
PD70 (660 ± 248 cells) (t-test, p = 0.93).  
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Figure 6.2 Numbers of fluorescent cells in M71-expressing strains 
Average OSN number for strains with gene-targeted mutations in the M71 locus at PD21 or PD70. The 
five mice of M71-IRES-tauGFP at PD21 in Figure 6.2 are the same as in Figure 6.1. 
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6.1.2  Sampling error 
 
Partial cell counts from sampling are typically reported in the literature, 
because of the time and effort required to make full cell counts. The 
availability of full cell counts provides a unique opportunity to determine 
exactly the error that would have been introduced by interleaved sampling. 
Data sets of n size were generated for the full cell counts, corresponding to 
nth section sampling for the core set of 11 strains (Figure 6.3); for example, 
there would be 10 data sets consisting of cell counts in each 10th section. For 
each data set, the cell counts were summed and multiplied by the sampling 
interval; in this example, multiplied with 10.  
 
Figure 6.3 Effect of sampling interval 
Average percentage of difference (error) in interleaved sampling compared to the "count every cell" 
approach (±SD). Errors for all tauGFP strains for each sampling interval were pooled to calculate the 
averages. A symbol represents a single virtual sampling set.   
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The error produced by interleaved sampling can then be calculated by 
comparing the summed counts of a virtual data set to the original full cell 
count. The error and standard deviation increase rapidly with decreased 
sampling interval, and are higher for strains with low OSN numbers such as 
P3-IRES-tauGFP than for strains with high OSN numbers such as MOR256-
17-IRES-tauGFP (Figure 6.4).  
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Figure 6.4 Sampling error per strain 
Error of cell counts by sampling interval for GFP-expressing strains sorted by average OSN number, 
from P3, low, to MOR256-17, high. A symbol represents a single virtual sampling set. 
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6.1.3 Coefficient of Variation 
 
The coefficient of variation (CV) is the ratio of standard deviation and 
average. Among the core set of 11 strains, the CV for the OSN number within 
a strain ranges over a factor of 3.2-fold, from 0.066 (mOR37C-IRES-tauGFP) 
to 0.21 (M71-IRES-tauGFP), but there is no correlation with average OSN 
number (Figure 6.5): MOR23-IRES-tauGFP has a similarly low CV (0.074) as 
SR1-IRES-tauGFP (0.072), but the number of OSNs is 5.5-fold lower. 
Conversely, M72-IRES-tauGFP has a CV (0.172) similar to that of MOR256-
IRES-tauGFP (0.171), but the number of OSNs is 7-fold lower. Thus, the 
probability of OR gene choice appears to be more constant for certain OR 
genes than for others. From a practical experimental viewpoint, FP-tagged 
strains with a higher stability in OSN population size (a lower CV) such as 
MOR23-IRES-tauGFP are easier to study quantitatively. 
 
 
Figure 6.5 Coefficient of variation.  
Coefficient of variation (CV) for average OSN number of the 11 tauGFP strains shows that there is no 
correlation between average OSN number and CV. The line is best modeled by y = 3.1*10-7x + 0.13 (r2 
= 0.008, p = 0.79). 
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6.1.4 Cell counts along the anterior-posterior dimensions of the main 
olfactory epithelium 
 
As described previously, OSNs expressing a given OR gene display a 
characteristic spatial pattern across the MOE (Ressler et al., 1993; Miyamichi 
et al., 2005). With the availability of full cell counts per 12 µm section, plotting 
the counts along the anterior-posterior dimension of the MOE became 
feasible. Figure 6.6 shows the diversity of these plots, reflecting the multitude 
of spatial expression patterns.  
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Figure 6.6 OSN counts across the anterior-posterior dimension of the main olfactory epithelium.  
Average OSN counts per section. The dotted red lines indicate two reference positions in a sagittal view 
of a mouse head. Strains were chosen for showing the diversity in expression per section. Cells in the 
septal organ are not included in these counts.  
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OR genes expressed dorsally such as M71 and MOR23 have a relatively 
even distribution, starting far anteriorly. The relatively even distribution of M71 
is maintained in mutations in which the M71 coding region is replaced by that 
of the β2-adrenergic receptor (β2AR➝M71-IRES-tauGFP) or in which M71 
translation is decreased by an IRES-mediated knockdown 
(RFP➝M71iM71iGFP) (Figure 6.7).  
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Figure 6.7 Average OSN counts along AP dimensions for strain expressing M71 
Average OSN counts per section for strains with mutations in the M71 gene along the anterior-posterior 
dimension showing a similar expression pattern even though the OSN numbers vary.  
 
In contrast OR genes show a single peak (MOR256-17) or two peaks 
(SR1) along the anterior-posterior dimension (Figure 6.8). These peaks 
compromise the accuracy of comparing partial cell counts among individual 
mice, due to the lack of fiduciary points. 
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Figure 6.8 OSN counts per section for strains compared to M71 
Average OSN counts per section of (tau)GFP-expressing strains (magenta) compared to M71-IRES-
tauGFP (green), sorted by average OSN number from P3, low, to MOR256-17, high. The strains display 
a multitude of spatial expression patterns/zones. 
 
6.1.5 Glomerular volume and cell counts 
 
The same series of coronal sections as for counting OSNs in the MOE was 
used to study the glomeruli that correspond to a fluorescent protein-tagged 
OSN population. The area of a glomerulus displaying intrinsic fluorescence 
can be calculated by confocal imaging in z-stacks, but this procedure for 
determining glomerular volume is very time-consuming. Therefore the 
glomerular volume was computed by reconstruction. The sum of the 
reconstructed volumes of all fluorescently labeled glomeruli in a mouse is the 
total glomerular volume (TGV).  
There is a strong linear correlation between OSN number and TGV among 
the 56 mice of the core set of 11 gene-targeted strains analyzed at PD21 
(Figure 6.9): r2=0.97 at p ≤ 0.0001 with an intercept of the Y axis at 168,700 
µm3 and a slope of 81.55. The practical implication of this linear correlation is 
that TGV, which is relatively easy to compute, can be used to estimate 
accurately OSN number, which is far more time-consuming to determine. 
 76 
 
Figure 6.9 Glomerular volume and correlation with OSN numbers for strains coexpressing 
tauGFP .  
TGV per strain at PD21 correlates strongly and linearly to the OSN number (r2 = 0.97, p-value ≤ 0.0001) 
in the core set of 11 strains. The curve is best modeled by y = 81.55x + 168,700. A symbol represents a 
single strain. 
 
A strong linear correlation exists as well when considering the strains with 
different marker genes for M71 (Figure 6.10): r2=0.97 at p = 0.0018 with an 
intercept of the Y axis at -55,627 µm3 and a slope of 121.1. However it was 
not possible to get a reliable glomerular volume measurement for the two 
β2AR➝M71 strains.  
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Figure 6.10 Glomerular volume and correlation with OSN numbers for M71-expressing strains  
TGV per M71-expressing strain at PD21 correlates strongly and linearly to the OSN number (r2 = 0.97, 
p-value = 0.0018) in the core set of 11 strains. The curve is best modeled by y = 121.1x - -55,627. A 
symbol represents a single strain. 
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6.1.6 Glomerular density 
 
Finally, fluorescent pixel density of labeled glomeruli was determined in the 
confocal images used for the reconstruction of glomerular volume. 
Fluorescent pixel density is an estimate for the density of OSN axon branches 
and axon terminals within a glomerulus. We find a relatively constant density 
of ~0.80 across the strains; a density of 0.80 means that 80% of the pixels in 
the glomerulus display fluorescence above background (Figure 6.11).  
 
 
Figure 6.11 Fluorescent pixel density in glomeruli per strains 
The ratio of fluorescent pixels to all pixels in the glomerular area is ~0.8 in all strains (ANOVA, F=21.50, 
p < 0.0001), except for S50-IRES-tauGFP. A symbol represents a single mouse. Strains are sorted by 
average OSN number from P3, low, to MOR256-17, high.  
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The S50 glomeruli have a value of 0.56. It turns out that the lateral S50 
glomeruli have a value of 0.40 (Figure 6.12). However the medial S50 
glomeruli have a normal value of 0.79 (Figure 6.13). 
 
 
Figure 6.12 Example of a lateral S50-IRES-tauGFP glomerulus  
The upper image illustrates the lower fluorescent pixel density in lateral S50 glomeruli, the lower image 
a medial S50 glomerulus. Green, intrinsic fluorescence; white, DAPI. Scale bar, 20 µm.   
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Explanations could be that lateral S50 glomeruli are not yet fully mature by 
PD21, that they have indeed a lower density of OSN axon branches and 
terminals, or that they are coinnervated by axons from OSNs expressing 
another OR. 
 
 
Figure 6.13 Ratios of axonal density for lateral versus medial S50-IRES-tauGFP glomeruli (±SD) 
This figure shows that only the lateral glomeruli have a lower fluorescent pixel density. A symbol 
represents the average of glomeruli in both bulbs of an individual mouse. 
 81 
6.2  Discussion 
 
The introduction of a genetic strategy based on an IRES and the axonal 
marker tauβ-galactosidase in 1996 (Mombaerts et al., 1996 ) and the later 
addition of fluorescent marker proteins (tauGFP and variants tauYFP and 
tauRFP2) became essential for multiple studies in the olfactory system: they 
facilitate imaging of glomeruli by confocal microscopy and two-photon 
microscopy (Potter et al., 2001), they enable physiological studies (Bozza et 
al., 2002;  Grosmaitre et al., 2006; Grosmaitre et al., 2009; Omura and 
Mombaerts, 2015), they allow for flow-cytometric cell sorting (Khan et al., 
2011) and the manual picking of single cells expressing a given OR gene (Li 
et al., 2004; Fuss et al., 2010). Therefore this chapter is focused on mice of 
strains with a gene-targeted mutation in an OR gene that generates a 
fluorescent protein.  
A lingering belief is that each of the ~1,100 OR genes is expressed in a 
similar number of OSNs. This chapter shows a factor of 17-fold between the 
smallest OSN population (P3-IRES-tauGFP) and the largest OSN population 
(MOR256-17-IRES-tauGFP) at PD21, in the 1% sample of the ~1,100 OR 
genes. Provisionally the median of 5,983 as the OSN number for the average 
OR gene at PD21 is the prudent estimate. In turn, this number of 5,983 results 
in an estimate of ~6.6 million OSNs expressing any of the 1,100 OR genes in 
a mouse at PD21 in this mixed 129 x B6 background. This estimate is lower 
than the estimate of ~9,400 OSNs expressing on average a given OR gene in 
the ~10 million mature, OMP-expressing OSNs in 8-week-old C57BL/6J mice 
(Kawagishi et al., 2014). But the age difference of 3 versus 8 weeks is 
substantial, and the fraction of OMP-expressing OSNs that does not express 
an OR gene is not known.  
A broad range of NanoString counts for OR mRNAs in wild-type C57BL/6 
mice was reported (Khan et al., 2011, 2013): 92% of OR genes have 
NanoString counts within a 32-fold range. These NanoString counts are not 
directly translatable into OSN numbers, for several reasons (Khan et al., 
2013). The probabilities of OR gene choice appear to differ widely across the 
OR gene repertoire, and the mechanistic basis of these differences remains to 
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be clarified. OSN survival and turnover are likely dependent on the odorant 
composition of the inhaled air which in turn may contribute to the innervation 
and activity of the OSNs. Therefore Chapter 3.1 contains information about 
the type of caging, food, and bedding being used. It is conceivable that OSN 
counts may be different in mice that are housed in other types of caging (such 
as open cages versus individually ventilated cages) or given other food and 
bedding.  
The empirical strategy generates total cell counts, which appear rarely in 
the literature presumably due to the amount of effort that is required. A rare 
example of total cell counts can be found in Royal and Key (1999). Counting 
cells expressing the OR gene P2 by X-gal histochemistry in P2-IRES-tauLacZ 
mice but without Abercrombie correction, Royal and Key reported 8,286 
labeled cells at PD14.5 and 13,729 at 12 weeks, whereas here 13,975 ± 
1,982 labeled cells at PD21 in P2-IRES-tauGFP mice are reported. 
It appears that the choice of marker proteins has a significant effect on the 
cell number for the M71 strain. A downregulation of the expression of M71 in 
the strain RFP➝M71iM71iGFP results not only in 68% less expression of the 
protein in the axon terminus (Zhang et al., 2012) but also in a 73% decrease 
in OSN number compared to M71-IRES-tauGFP at PD21. The decrease in 
OSN number in RFP➝M71iM71iGFP is also correlated with TGV. The 
significant higher OSN numbers for the strain M71-IRES-taulacZ compared to 
M71-IRES-tauGFP could be further verified by performing RNA in situ 
hybridization of M71 specific probe on C57BL/6J tissue section. However, 
generation of M71 specific probe proved to be challenging since M71 and 
M72 genes are highly homologous to each other. 
From the complete data sets n virtual data sets were generated, as if cells 
on every nth section had been counted, in n successive data sets, calculating 
the exact error that is produced by interleaved sampling. This chapter reports 
that, as expected, the standard deviation increases rapidly with increasing 
interval, reaching ±5.63 for every 20th section (average error 5.75%). The 
information provided about the 11 strains enables now to define a priori the 
acceptable error for studies in which cell counts are compared between 
experimental conditions. 
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Counting OSNs expressing a given OR gene or fluorescent protein remains 
a manual enterprise, no reliable automated methods have been developed 
thus far. This chapter reports a surrogate for cell counting, computing TGV, 
which takes far less effort. Reconstruction of these volumes can be done 
easily by measuring the glomerular area in the middle optical section of 
physical sections under a confocal microscope, reducing the number of 
sections analyzed drastically (see Chapter 6.1.2). The very strong linearity of 
the correlation between OSN number and TGV, over a range of 17-fold, 
implies that estimates of OSN numbers can be read out from the provided 
dataset. These findings are consistent with the linear correlation that has been 
described between partial cell counts in the MOE of M71-IRES-taulacZ mice 
and the average largest cross-sectional area of an M71 glomerulus (Jones et 
al., 2008).  
OSN number estimates derived from TGV may be sufficiently accurate 
depending on the goals of the study and the number of mice that need to be 
analyzed. The linearity of this correlation is not entirely surprising but also not 
obvious. One could have expected that at low and high OSN numbers the 
curve would flatten out - in particular at lower OSN numbers, as conceivably a 
fixed minimum volume of a glomerulus could be occupied by non-axonal 
structures.  
Another limitation of our studies is that they are based on mice in the 
conventional mixed 129 x B6 background, which is currently the best practice. 
Backcrossing of the targeted mutations to C57BL/6 may help in reducing 
some of the variability. But as most of OR gene regulation takes place in cis, 
at the promoter level, the regions around the targeted OR locus will always be 
of 129 origin - in fact, they will continue to be the nucleotide sequences that 
were present in the genome of the original embryonic stem cell in which the 
targeted mutation was introduced. New genetic manipulation technologies like 
CRISPR/Cas9 might generate FP-tagged mutations in a C57BL/6 background. 
It will then also be possible to compare cell numbers between counting 
fluorescent cells in FP-tagged strains with counting cells expressing the 
corresponding unmanipulated OR gene in wild-type C57BL/6 mice by RNA in 
situ hybridization. 
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In conclusion, the practical outcome of this empirical study is that TGV is a 
highly reliable indicator of OSN number. 
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7 Conditional knockout of Neuropilin-1 in M71-
expressing OSNs 
 
7.1 Results 
 
Neuropilin-1 (Nrp1) is expressed in several different types neurons (Gu et 
al., 2003). As described in Chapter 2.8, Nrp1 is one of the major factors in 
axonal wiring in the mouse olfactory system. A conditional knockout of Nrp1 
(Imai et al., 2009) moves the glomerular position of OSNs, expressing a 
transgene rat I7 from the MOR23 promoter, to a more anterior position in the 
bulb. In heterozygous conditional Nrp1 knockout mice, an intermediate 
position was observed. However Imai and colleagues (2009) used a 
transgene approach, by random integration of a rat OR (rI7) under the 
MOR23 promoter somewhere in the genome.  
This chapter describes the phenotype of gene-targeted conditional 
knockout of Nrp1 in M71 OSNs. I found that M71-expressing OSNs that are 
devoid of Nrp1 form ectopic glomeruli at the anterior tip of the OB but also 
maintain glomerular coalescence in their typical position in the bulb, 
comparable to M71-IRES-tauGFP. 
 
7.1.1 Breeding strategy  
 
To study the effects of a conditional knockout of Nrp1 in OSNs, a genetic 
approach was chosen. The idea is to study axons expressing a certain OR 
and deficient for Nrp1 and compare them, in the same mouse, to axons 
expressing the same OR but not deficient for Nrp1. The unusual feature of 
monoallelic and monogenic expression of an OR gene enabled this strategy. 
To generate the crosses described in this chapter, gene-targeted strains 
expressing M71 were chosen because these are some of the most described 
and characterized strains available. Two Nrp1 conditional knockout alleles 
were used, resulting in two different strains which both were the result of a 
triple cross (Figure 7.1). The two conditional Nrp1 alleles are: Nrp1-flox/J was 
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generated in our lab (unpublished) and npn1-5247 (JR#5247), the same allele 
as used by Imai and colleagues (2009). 
 
 
Figure 7.1 Breeding scheme for conditional Nrp1 knock out strain 
This figure illustrates the crosses set up for the Nrp1 knockout strain. After crossing each strain, the 
offspring was intercrossed until the cross was homozygous for all genes of interest. Then the next strain 
was crossed to the previous cross and the process was repeated. The end result was four strains 
(NMCZ, n5247MCZ) with a conditional knockout of Nrp1 in M71-expressing neurons (with one of two 
different conditional alleles for Nrp1) and two strains that express normal levels of Nrp1 (NMRZ, 
n5247MRZ) where M71 coexpresses RFP2. Mating these crosses results in the desired compound 
heterozygous strains (NMRCZ, n5247MRCZ) where M71-expressing OSNs expressing Nrp1 coexist 
with M71-expressing OSNs not expressing Nrp1. 
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Each of the two crosses contains Nrp1 mutated with loxP sites for 
conditional knockout and the Z/EG transgene as a reporter for the expression 
of the Cre recombinase. The difference is the M71-expressing strain crossed 
to Nrp1-flox and Z/EG: 
 - crossing to M71-IRES-tauRFP2 should have no effect and should have the 
same phenotype as M71-IRES-tauRFP2 on its own. 
 - crossing to M71-IRES-Cre should knockout Nrp1 the loxP-flanked site  in 
Z/EG resulting in conditional Nrp1 knockout phenotype and the expression of 
GFP. 
Crossing the two homozygous triple crosses results in the desired 
compound heterozygous quadruple mutant strain (Figure 7.2). 
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Figure 7.2 Conditional knockout in gene-targeted quadruple mutants 
(A) All OSNs expressing the allele M71-IRES-tauRFP2 have normal levels of endogenous Nrp1 
expression and coalesce into glomeruli at a position that is typical for M71 glomeruli (red dot). (B) In 
OSNs expressing the allele M71-IRES-Cre the Cre recombinase is expressed (yellow star) excising 
Nrp1 and the loxP-flanked β-galactosidase including the stop codon from the Z/EG transgene, enabling 
GFP expression. These axons coalesce into an ectopic, anterior position (green dot). 
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7.1.2 Nrp1 knockout 
 
Another cross was created to examine the global effect of Nrp1 on axonal 
wiring in the mouse olfactory system. The Nrp1-flox strains were crossed to 
the Z/EG reporter transgene and the OMP-Cre strain. OMP, the olfactory 
marker protein, is expressed in all mature OSNs. In the OMP-Cre strain, the 
OMP coding sequence is replaced with the Cre recombinase. The knockout of 
Nrp1 in all mature OSNs has no discernible overall effect on axonal wiring. 
The glomeruli are formed apparently normally, and the glomerular layer lacks 
Nrp1 staining for Nrp1 antibody (Figure 7.3).   
  
 
Figure 7.3 Nrp1 knockout in OMP-expressing OSNs 
Horizontal section of PD21 olfactory bulb taken with the Aperio Scanscope shows intrinsic fluorescence 
of OMP-Cre x Z/EG expressing neurons (green) and antibody staining for Nrp1 (red). The distribution, 
size and form are similar to glomeruli expressing Nrp1. The right image illustrates the different layers of 
the olfactory bulb: Olfactory nerve layer (PNL), glomerular layer (Glom), external plexiform layer (EPL), 
mitral cell layer (MT), internal plexiform layer (IPL) and granule layer (GrL). Only background Nrp1 
staining is detected in the glomerular layer of knockout strain (Scale bar: 250 µm). 
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Although the axonal wiring seems to be not affected by a knockout of Nrp1 
in OMP-expressing neurons, antibody staining shows a lack of staining for 
Nrp1 in the glomerular layer of the OB compared to strains with normal 
expression of Nrp1 (Figure 7.4). The antibody staining for Nrp1 in NOCZ mice 
confirms the effectiveness of the conditional Nrp1 knock out using Nrp1-flox/J. 
 
 
Figure 7.4 Comparison of Nrp1 expression 
Horizontal section of PD21 olfactory bulb taken with the Aperio Scanscope compares intensity of Nrp1 
antibody staining (red) in mice with an knockout of Nrp1 in OMP-expressing OSNs (A) compared to 
staining intensity in mice with normal Nrp1-expression (B, M71-IRES-Cre x R26-STOPtauGFP). White 
arrowheads indicate that Nrp1 is still expressed in the knockout in layers other than glomerular layer. 
Green signal in B references the medial glomerular position of M71-IRES-Cre expressing OSNs (yellow 
arrowhead). Scale bars: 250 µm. 
 
7.1.3 Ectopic glomerulus 
 
The phenotype of the Nrp1 knockout in M71-expressing OSNs is a robust 
and consistent observation in all analyses. A new glomerulus is formed on the 
medial side in the dorsal anterior bulb. However there are still labeled axons 
converging onto glomeruli in the posterior area of the OB. In general a 
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singular glomerulus is formed in a dorsal, central area between the medial 
and lateral position of the normal M71 glomeruli (Figure 7.5). Often an 
additional glomerulus is formed in the dorsal medial area close to the area 
normally occupied by M71-expressing axons. 
   
 
Figure 7.5 Comparison of M71 strains for Nrp1 knockout 
(A) Dorsal view of a whole mount of a M71-IRES-Cre x R26-tauGFP PD21 bulb, imaged with NIKON, 
showing the intrinsic fluorescence. White arrowheads show normal glomerular positions for M71-
expressing OSNs. (B) Dorsal view of a n5247MCZ PD21 bulb showing intrinsic fluorescence. White 
arrowheads show ectopic glomeruli for Nrp1 negative M71 axons. Scale bars: 500 µm. 
 
7.1.4 Mixed glomeruli in conserved glomerular position 
 
The phenotypes of the ectopic anterior glomeruli in dorsal medial position 
as well as of the shifted lateral glomeruli are conserved in all knockout strains. 
For more details on the axon composition of the glomeruli of the NMRCZ 
compound heterozygous animals, 12 µm coronal sections of the bulb at PD21 
and PD70 were taken.  
The posterior glomeruli in conserved medial M71 position in the NMRCZ 
strain are heterozygous for the M71 alleles. The shifted glomeruli, which are 
along the anterior-posterior axis at the same height as the normal M71 
glomerular position, are shifted more dorsally and often appear to be 
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fragmented into several small glomeruli (Figure 7.6). If a glomerulus is formed 
at the normal M71 position, it is heterozygous for Nrp1-deficient axons and 
M71 axons with normal Nrp1 expression.  
 
 
Figure 7.6 Axonal wiring in a whole mount NMRCZ mouse 
Confocal image of a whole mount of a PD14 NMRCZ mouse. White arrowheads indicate ectopic 
glomeruli only formed by M71 axons deficient of Nrp1 (intrinsic fluorescence, green). Yellow arrowheads 
indicate heterozygous glomeruli at the normal M71 glomerular position, consisting of Nrp1-deficient 
axons and axons with normal Nrp1 expression (intrinsic fluorescence, green; Nrp1, red). White dashed 
line shows the outline of the olfactory bulb. Scale bar: 500 µm. 
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In the heterozygous glomeruli both axons intermingle, only in one single 
NMRCZ mouse a compartmentalization was observed at PD70 (Figure 7.7). 
This glomerulus shows the different Nrp1 expression levels for the M71 alleles. 
 
 
Figure 7.7 Heterozygous NMRCZ medial glomerulus 
The left image shows 12 µm coronal section of a NMRCZ mouse at PD70 and axons of both M71 alleles 
forming a heterozygous glomerulus with Nrp1 deficient axons (intrinsic fluorescence, green) and axons 
with normal Nrp1 expression (antibody staining for tauRFP2, red). The right image shows the Nrp1 
antibody staining in the same glomerulus (blue). A stronger staining for Nrp1 is clearly visible (yellow 
arrow) at positions occupied by the red axons in the left figure with normal Nrp1 expression. Scale bar: 
25 µm.     
  
For all mice analyzed, the ectopic anterior glomeruli consist of GFP stained 
M71 OSNs, which show only background levels of Nrp1 antibody staining 
(Figure 7.8). 
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Figure 7.8 M71 OSN ectopic glomerulus 
Coronal section of a PD70 ectopic glomerulus of the NMRCZ strain (12 µm thickness). The green M71-
IRES-Cre expressing axons form small homogeneous ectopic glomeruli (intrinsic fluorescence, left) 
while the Nrp1 antibody staining (blue) in that glomerulus is absent from the green axons (right). Scale 
bar: 25 µm  
  
7.1.5 Nrp1 knock out phenotype at various ages 
 
The phenotype of ectopic anterior glomerulus starts forming directly after 
birth in n5247MCZ mice. Axons project to the anterior ectopic position as well 
as to the posterior, normal M71 glomerular position (Figure 7.9). 
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Figure 7.9 Axonal wiring of n5247MCZ mice in neonatal mice 
Dorsal view of a whole mount of a of PD0 n5247MCZ mouse. The white arrowheads show nascent 
glomeruli forming at the ectopic anterior position and the posterior, normal M71 position. Glomeruli are 
not fully formed yet but already project to the position typical for this phenotype. Scale bar: 100 µm.  
 
Likewise the Nrp1 knockout phenotype remains well conserved at PD140 
(Figure 7.10). The ectopic glomeruli are still present and a posterior medial 
glomerulus is maintained at the normal M71 medial position. The lateral 
posterior glomerulus is shifted more dorsally and dispersed into several small 
glomeruli compared to M71. 
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Figure 7.10 Axonal wiring in old NMRCZ mice 
Dorsal view of a whole mount the olfactory bulb of a NMRCZ PD140 mouse taken with NIKON 
stereoscope. White arrowheads indicate glomeruli formed by M71-expressing axons deficient for Nrp1 
(intrinsic fluorescence, green). Axons of M71-expressing OSNs with normal Nrp1 expression are not 
shown in this image. Scale bar: 500 µm 
 
To evaluate for the stability of the phenotype through life, several age 
groups were chosen for analysis. The compound heterozygous knockout 
strain NMRCZ was analyzed at young age of PD7, PD14 (the same age as 
the mice reported by Imai et al. (2009)) and PD21, in young adults at PD35 
and adults at PD70, and finally in aged mice at PD140. In each age group the 
reported phenotype is present and well conserved (Table 7.1).   
For the homozygous knockout strain n5247MCZ the age PD21 as the lab 
standard age and PD0 were analyzed. These also show the phenotype (Table 
7.1).  
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Table 7.1 Table of age and number of mice investigated for Nrp1 knock out strain 
Strains PD0 PD7 PD14 PD21 PD35 PD70 PD140 
NMRCZ  
Ectopic 
anterior 
glomeruli 
 
Mixed 
medial 
posterior 
glomeruli 
 
Ectopic 
pos. 
med. 
Glomeruli 
Ectopic 
anterior 
glomeruli 
 
Mixed 
medial 
posterior 
glomeruli 
 
Ectopic 
pos. med. 
Glomeruli 
Ectopic 
anterior 
glomeruli 
 
Mixed 
medial 
posterior 
glomeruli 
 
Ectopic 
pos. med. 
Glomeruli 
Ectopic 
anterior 
glomeruli 
 
Mixed 
medial 
posterior 
glomeruli 
 
Ectopic 
pos. med. 
Glomeruli 
Ectopic 
anterior 
glomeruli 
 
Mixed 
medial 
posterior 
glomeruli 
 
Ectopic 
pos. med. 
Glomeruli 
Ectopic 
anterior 
glomeruli 
 
Mixed 
medial 
posterior 
glomeruli 
 
Ectopic 
pos. med. 
Glomeruli 
Numbers  7 7 6 5 5 2 
n5247MCZ 
Axons 
branch at 
ectopic 
and 
posterior 
position 
 
Glomeruli 
are not 
formed 
  
Ectopic 
anterior 
glomeruli 
 
(Medial 
posterior 
glomeruli) 
 
Ectopic 
pos. med. 
Glomeruli 
   
Numbers 3   7    
 
7.1.6 Control experiments 
 
To test if the knockout of Nrp1 has an effect on OSN numbers, mice from 
the NMRCZ strain (n=4) and n5247MCZ (n=3) strain where perfused at PD21 
and cells were counted as described in Chapter 4.9. There was no significant 
difference between NMRCZ (t-test, p=0.053), n5247MCZ (t-test, p= 0.76) and 
M71-IRES-tauGFP mice (Figure 7.11). In the case of NMRCZ cells expressing 
either allele were evaluated separately and there was no significant difference 
between the OSN numbers between the two alleles (t-test, p=0.85); each 
contributing half to the total OSN number of the NMRCZ strain, in keeping 
with the monoallelic property of an OSN.  
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Figure 7.11 OSN numbers for Nrp1 knockout strains 
OSN numbers of PD21 Nrp1 knockout strains (±SD). Each symbol represents a single mouse. M71-
IRES-tauGFP and M71-IRES-tauRFP2 are the same data as reported in Chapter 6 for comparison.  
M71-IRES-Cre(het) and M71-IRES-tauRFP2(het) are the OSNs for the individual M71 alleles of 
NMRCZ, added together totally in the NMRCZ results. 
  
7.2 Discussion 
   
Axonal wiring in the mouse olfactory system remains poorly understood a 
quarter century after the discovery of OR genes. One of the most impressive 
feats of the olfactory system is its ability to establish and maintain conserved 
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glomeruli homogeneous for axons expressing a specific OR in the olfactory 
bulb, given there are around 1,100 different OSN types. Gradients of cell 
adhesion molecules are one of several possible explanations for the 
mechanism of the precise axonal wiring, with Nrp1 being one of the most 
prominent members. A popular model attributes the glomerular position along 
the anterior-posterior axis of the olfactory bulb to an increasing gradient of 
Nrp1 along this axis (Imai et al., 2009). Nakashima et al., 2013 link the 
expression of Nrp1 to the basal activity of the OR expressed in the OSNs. The 
higher basal activity in developing OSNs is translated with a signal 
transduction cascade to a stronger expression of Nrp1 and thus a more 
posterior position in the OB. However Schwarting et al. (Pasterkamp et al., 
1998) reported antibody stainings in rat that show that Nrp1 is not expressed 
in a simple gradient along the anterior-posterior axis and that the repulsive 
ligand for Nrp1, Semaphorin 3A (Sema3A), is expressed in a lateral and 
medial area of the bulb (Schwarting et al., 2004).  
The results reported in this chapter also show that the axonal wiring along 
the anterior-posterior axis is not simply dependent on a Nrp1 gradient. A 
conditional knockout of Nrp1 in M71-expressing OSNs results in a stable 
phenotype, where the normal two dorsal posterior M71 glomeruli per bulb 
(one medial, one lateral) in most cases still exist but other small ectopic 
glomeruli are formed in addition. Most prominent and stable is the ectopic 
glomerulus at the anterior tip of the OB. As this ectopic glomerulus this also 
formed in mice with a homozygous conditional knockout of Nrp1 in M71-
expressing OSNs, it is unlikely that the axons with normal Nrp1 expression in 
the compound heterozygous mice somehow rescue the Nrp1-deficient axons. 
I speculate that the axons with normal Nrp1 expression help to stabilize the 
glomeruli at the normal M71 position, because they appear more often in the 
NMRCZ strain than in n5247MCZ mice. Using a gene-targeting approach 
these strains are closer to the wild-type situation than transgenic mice. It 
appears that other factors are also involved in determining the position of a 
glomerulus. Nrp1 is definitely an important factor in axonal wiring in the OB 
but it is not the only one, at least for M71. 
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Another interesting observation is that the phenotype is remarkably similar 
to a conditional knockout of the adenylyl cyclase 3 (AC3) in OSNs. Both 
studies, one investigating the axons in M72 mice (Col et al., 2007) and the 
other one those in M71 mice (Zou et al., 2007), show a similar phenotype of 
an ectopic glomeruli at the anterior tip of the bulb. Both strains are closely 
related and axons of their OSNs terminate in the same area of the bulb. In 
most instances the glomeruli of M71 and M72 are adjacent. As M72 has a 
higher number of OSNs than M71 (Chapter 6) an additional ectopic 
glomerulus on the lateral side may be able to form stable in the lateral half 
(Col et al., 2007).  
The similarity of the AC3 knockout phenotype and the phenotype of Nrp1 
knockout strongly suggests that the signal transduction cascade mediated by 
cyclic AMP (cAMP) is an important factor in the expression of Nrp1. Normally 
Nrp1 does not use cAMP as a second messenger but perhaps another 
unknown factor is regulated by cAMP. It is possible that this factor is 
responsible for the complex task to sort 1,100 different kinds of axons into 
glomeruli at conserved positions, and that this factor is somehow regulated by 
Nrp1.  
In summary the two Nrp1 knockout strains reported in this chapter have an 
interesting phenotype similar to the effect that an AC3 knockout has on M71-
expressing OSNs but unlike the conditional knockout in a transgene mouse 
reported by Imai and colleagues (2006).   
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8 Final Discussion 
 
In this thesis I have studied several aspects of the complex mechanisms of 
axonal wiring in the mouse olfactory system. I set out originally to determine 
the effect of caGs in M71-expressing OSNs by generating novel strains of 
gene-targeted strains. My guess is that it would not have shifted the position 
of M71 glomeruli further posteriorly. However due to persistent difficulties of 
generating an appropriate targeting vector and because of time constraints I 
did not continue this project and focussed on the two other aspects reported 
here. 
The second project was a comprehensive empirical study of the distribution 
and number of OSNs in the olfactory epithelium. Such a study has not been 
conducted before, and became only possible because of the fortune of a large 
collection of gene-targeted strains coexpressing tauGFP with individual ORs 
in the lab. This resource enabled a broad insight into the fundamental 
constituents (OSNs and glomeruli) of axonal wiring, showing the strong 
correlation between the two. It also quantified and showed possible pitfalls of 
sampling of OSN numbers, with determining sampling errors for the strains, 
showing their different expression patterns and determining the stability of 
OSN numbers in each strain. My results indicate that OSNs expressing 
MOR23 should be used for further, quantitative studies because of the 
stability of this population. 
In the third project the role of Nrp1 in axonal wiring was investigated. 
Recent studies support a direct effect of a Nrp1 gradient on glomerular 
position along the anterior-posterior axis of the olfactory bulb, but these 
studies could not explain satisfactorily the monumental task of sorting ~1,100 
populations of OSNs so neatly and precisely into glomeruli. The results of a 
conditional knockout of Nrp1 in M71-expressing OSNs reveal that a simple 
gradient of Nrp1 cannot be the only factor that determines the anterior-
posterior position of a glomerulus. Surveying the research done on axonal 
wiring in the mouse olfactory system I favour the model of a zip code. Several 
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molecules contain part of the information to which region within in the 
glomerular layer the axon has to grow. With the knockout of one molecule or 
of one signalling cascade, in this case Nrp1 or AC3, axons projected 
additionally to ectopic positions due to the distorted code.  
 
In conclusion I was able to contribute basic and quantitative empirical data 
for further research to build upon.  I also provided some interesting insights 
into one of the many aspects of the complex and fascinating mechanism of 
axonal wiring: Nrp1 is an important factor for OSN axonal pathfinding, 
however, the mechanism is more complex and a simple gradient of the 
expression of Nrp1 cannot explain the findings.  
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10.2 Genetic sequences 
 
10.2.1 Vector insert 
 
caGs (1185 bp) 
ATGGGCTGCCTCGGCAACAGTAAGACCGAGGACCAGCGCAACGAGGAGAAGGCGCAGCGCGAGGCCAACAAA
AAGATCGAGAAGCAGCTGCAGAAGGACAAGCAGGTCTACCGGGCCACGCACCGCCTGCTGCTGCTGGGTGCT
GGAGAGTCTGGCAAAAGCACCATTGTGAAGCAGATGAGGATCCTGCATGTTAATGGGTTTAACGGAGAGGGCG
GCGAAGAGGACCCGCAGGCTGCAAGGAGCAACAGCGATGGTGAGAAGGCCACTAAAGTGCAGGACATCAAAA
ACAACCTGAAGGAGGCCATTGAAACCATTGTGGCCGCCATGAGCAACCTGGTGCCCCCTGTGGAGCTGGCCAA
CCCTGAGAACCAGTTCAGAGTGGACTACATTCTGAGCGTGATGAACGTGCCGAACTTTGACTTCCCACCTGAAT
TCTATGAGCATGCCAAGGCTCTGTGGGAGGATGAGGGAGTGCGTGCCTGCTACGAGCGCTCCAATGAGTACCA
GCTGATTGACTGTGCCCAGTACTTCCTGGACAAGATTGATGTGATCAAGCAGGCCGACTACGTGCCAAGTGACC
AGGACCTGCTTCGCTGCCGTGTCCTGACCTCTGGAATCTTTGAGACCAAGTTCCAGGTGGACAAAGTCAACTTC
CACATGTTCGATGTGGGCGGCCTGCGCGATGAGCGCCGCAAGTGGATCCAGTGCTTCAATGATGTGACTGCCA
TCATCTTCGTGGTGGCCAGCAGCAGCTACAACATGGTCATTCGGGAGGACAACCAGACTAACCGCCTGCAGGA
GGCTCTGAACCTCTTCAAGAGCATCTGGAACAACAGATGGCTGCGCACCATCTCTGTGATTCTCTTCCTCAACAA
GCAAGACCTGCTTGCTGAGAAAGTCCTCGCTGGCAAATCGAAGATTGAGGACTACTTTCCAGAGTTCGCTCGCT
ATACCACTCCTGAGGATGCGACTCCCGAGCCCGGAGAGGACCCACGCGTGACCCGGGCCAAGTACTTCATTCG
GGATGAGTTTCTGAGAATCAGCACTGCTAGTGGAGATGGGCGCCACTACTGCTACCCTCACTTTACCTGCGCCG
TGGACACTGAGAACATCCGCCGTGTCTTCAACGACTGCCGTGACATCATCCAGCGCATGCATCTCCGCCAATAC
GAGCTGCTCTAA 
 
IRES (589 bp) 
CCGCGGCAATTCCGCCCCTCTCCCTCCCCCCCCCCTAACGTTACTGGCCGAAGCCGCTTGGAATAAGGCCGGT
GTGCGTTTGTCTATATGTTATTTTCCACCATATTGCCGTCTTTTGGCAATGTGAGGGCCCGGAAACCTGGCCCTG
TCTTCTTGACGAGCATTCCTAGGGGTCTTTCCCCTCTCGCCAAAGGAATGCAAGGTCTGTTGAATGTCGTGAAG
GAAGCAGTTCCTCTGGAAGCTTCTTGAAGACAAACAACGTCTGTAGCGACCCTTTGCAGGCAGCGGAACCCCCC
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ACCTGGCAACAGGTGCCTCTGCGGCCAAAAGCCACGTGTATAAGATACACCTGCAAAGGCGGCACAACCCCAG
TGCCACGTTGTGAGTTGGATAGTTGTGGAAAGAGTCAAATGGCTCTCCTCAAGCGTATTCAACAAGGGGCTGAA
GGATGCCCAGAAGGTACCCCATTGTATGGGATCTGATCTGGGGCCTCGGTGCACATGCTTTACATGTGTTTAGT
CGAGGTTAAAAAAACGTCTAGGCCCCCCGAACCACGGGGACGTGGTTTTCCTTTGAAAAACACGATGATAAT 
IRES-gapCFP (1383 bp) 
CCGCGGCAATTCCGCCCCTCTCCCTCCCCCCCCCCTAACGTTACTGGCCGAAGCCGCTTGGAATAAGGCCGGT
GTGCGTTTGTCTATATGTTATTTTCCACCATATTGCCGTCTTTTGGCAATGTGAGGGCCCGGAAACCTGGCCCTG
TCTTCTTGACGAGCATTCCTAGGGGTCTTTCCCCTCTCGCCAAAGGAATGCAAGGTCTGTTGAATGTCGTGAAG
GAAGCAGTTCCTCTGGAAGCTTCTTGAAGACAAACAACGTCTGTAGCGACCCTTTGCAGGCAGCGGAACCCCCC
ACCTGGCAACAGGTGCCTCTGCGGCCAAAAGCCACGTGTATAAGATACACCTGCAAAGGCGGCACAACCCCAG
TGCCACGTTGTGAGTTGGATAGTTGTGGAAAGAGTCAAATGGCTCTCCTCAAGCGTATTCAACAAGGGGCTGAA
GGATGCCCAGAAGGTACCCCATTGTATGGGATCTGATCTGGGGCCTCGGTGCACATGCTTTACATGTGTTTAGT
CGAGGTTAAAAAAACGTCTAGGCCCCCCGAACCACGGGGACGTGGTTTTCCTTTGAAAAACACGATGATAATAT
GCTGTGCTGTATGAGAAGAACCAAGCAGGTGGAAAAGAACGATGAGGACCAGAAGATCGTGAGCAAGGGCGAG
GAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTG
TCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTG
CCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTGGGGCGTGCAGTGCTTCAGCCGCTACCCCGACCAC
ATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGA
CGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAA
GGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACATCAGCCACAACGTC
TATATCACCGCCGACAAGCAGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGACGGCA
GCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACC
ACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTT
CGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAAAGCGGCCAATCCCGCGG 
 
IRES-tauGFP-ACNF (6267 bp) 
CGCCCCCCCCCCCCCCCCCCCTCTCCCTCCCCCCCCCCTAACGTTACTGGCCGAAGCCGCTTGGAATAAGGCC
GGTGTGCGTTTGTCTATATGTTATTTTCCACCATATTGCCGTCTTTTGGCAATGTGAGGGCCCGGAAACCTGGCC
CTGTCTTCTTGACGAGCATTCCTAGGGGTCTTTCCCCTCTCGCCAAAGGAATGCAAGGTCTGTTGAATGTCGTG
AAGGAAGCAGTTCCTCTGGAAGCTTCTTGAAGACAAACAACGTCTGTAGCGACCCTTTGCAGGCAGCGGAACCC
CCCACCTGGCGACAGGTGCCTCTGCGGCCAAAAGCCACGTGTATAAGATACACCTGCAAAGGCGGCACAACCC
CAGTGCCACGTTGTGAGTTGGATAGTTGTGGAAAGAGTCAAATGGCTCTCCTAAGCGTATTCAACAAGGGGCTG
AAGGATGCCCAGAAGGTACCCCATTGTATGGGATCTGATCTGGGGCCTCGGTGCACATGCTTTACATGTGTTTA
GTCGAGGTTAAAAAAACGTCTAGGCCCCCCGAACCACGGGGACGTGGTTTTCCTTTGAAAAACACGATGATAAT
ATGGCCACAACCATGGCTGAGCCCCGCCAGGAGTTCGACGTGATGGAAGATCATGCTCAGGGGGACTACACCC
TGCAAGACCAGGAGGGTGACATGGACCCCGGCCTGAAAGAGTCTCCCCTGCAGACCCCGGCCGATGATGGAT
CTGAGGAACCAGGCTCTGAAACCTCTGATGCTAAGAGCACTCCGACGGCGGAAGATGCGACAGCACCCTTAGT
GGATGAGGGAGCCCCCGGTGAGCAGGCGGCCGCTCAGGCCCCCGCGGAGATCCCAGAAGGAACCGCAGCTG
AAGAAGCAGGCATTGGCGACACGTCCAACCTGGAAGACCAAGCTGCCGGACACGTGACCCAAGCTCGCATGGT
CAGTAAAGGCAAAGATGGGACTGGACCCGATGACAAAAAAACCAAGGGGGCGGATGGTAAGCCTGGAACGAAG
ATTGCCACACCCCGGGGAGCAGCCCCTCCAGGCCAGAAAGGCCAGGCCAACGCCACCCGGATTCCAGCAAAA
ACCACTCCCACCCCGAAGACCTCGCCAGGTGAATCTGGGAAATCCGGGGACCGCAGCGGCTACAGCAGCCCC
GGCTCCCCAGGCACTCCGGGCAGCCGCTCCCGCACACCCTCCCTGCCGACCCCGCCCACCCGGGAGCCCAA
GAAGGTGGCGGTGGTCCGCACTCCCCCCAAGTCGCCGTCTGCAGCCAAGAGCCGCCTGCAGGCCGCTCCCGG
GCCCATGCCAGACCTGAAGAACGTCAAGTCCAAAATCGGCTCCACGGAAAACCTGAAGCACCAGCCAGGAGGT
GGCAAGGTGCAGATAATTAATAAGAAGCTGGATCTTAGCAACGTCCAGTCCAAGTGTGGCTCAAAGGATAATAT
CAAACACGTGCCAGGAGGCGGCAGTGTGCAAATAGTCTACAAACCAGTGGATCTGAGCAAGGTGACCTCCAAG
TGTGGCTCATTAGGCAACATCCATCATAAGCCAGGAGGTGGCCAAGTGGAAGTGAAATCTGAGAAGCTGGACTT
CAAGGATAGAGTCCAGTCGAAGATTGGGTCCCTGGACAACATCACACACGTCCCTGGCGGAGGGAATAAAAAG
ATCGAAACCCACAAGCTGACCTTCCGCGAGAACGCCAAAGCCAAGACCGACCACGGGGCGGAGATCGTGTCC
GGGGATCCACCGGTCGCCACCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTC
GAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGC
AAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGA
CCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCC
CGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAG
TTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGG
GGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAG
GTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCC
CCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACC
CCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGA
GCTGTACAAGTAAAGCGGCCGCGACTCTAGAGATTCGAGATCTAGATATCGATGAATTCATAACTTCGTATAATG
TATGCTATACGAAGTTATGGATCTGTCGATCGACGGATCGATCCGAACAAACGACCCAACACCCGTGCGTTTTAT
TCTGTCTTTTTATTGCCGATCCCCTCAGAAGAACTCGTCAAGAAGGCGATAGAAGGCGATGCGCTGCGAATCGG
GAGCGGCGATACCGTAAAGCACGAGGAAGCGGTCAGCCCATTCGCCGCCAAGCTCTTCAGCAATATCACGGGT
AGCCAACGCTATGTCCTGATAGCGGTCCGCCACACCCAGCCGGCCACAGTCGATGAATCCAGAAAAGCGGCCA
TTTTCCACCATGATATTCGGCAAGCAGGCATCGCCATGGGTCACGACGAGATCCTCGCCGTCGGGCATGCGCG
CCTTGAGCCTGGCGAACAGTTCGGCTGGCGCGAGCCCCTGATGCTCTTCGTCCAGATCATCCTGATCGACAAG
ACCGGCTTCCATCCGAGTACGTGCTCGCTCGATGCGATGTTTCGCTTGGTGGTCGAATGGGCAGGTAGCCGGA
TCAAGCGTATGCAGCCGCCGCATTGCATCAGCCATGATGGATACTTTCTCGGCAGGAGCAAGGTGAGATGACA
GGAGATCCTGCCCCGGCACTTCGCCCAATAGCAGCCAGTCCCTTCCCGCTTCAGTGACAACGTCGAGCACAGC
TGCGCAAGGAACGCCCGTCGTGGCCAGCCACGATAGCCGCGCTGCCTCGTCCTGCAGTTCATTCAGGGCACC
GGACAGGTCGGTCTTGACAAAAAGAACCGGGCGCCCCTGCGCTGACAGCCGGAACACGGCGGCATCAGAGCA
GCCGATTGTCTGTTGTGCCCAGTCATAGCCGAATAGCCTCTCCACCCAAGCGGCCGGAGAACCTGCGTGCAAT
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CCATCTTGTTCAATGGCCGATCCCATATTGGCTGCACGGATCCTGAACGGCAGAGGTTACGGCAGTTTGTCTCT
CCCCCTTCCGGGAGCCACCTTCTTCTCCAACCGTCCCGGTCGCGCTCTCGGCGCTTCTGAGGAGAGAACTGGC
TGAGTGACGCCCTTTATAGATTCGCCCTTGTGTCCCGCCCCTTCCTTTCCCGCCCTCCCTTGCGCTACGGGGCC
GCCCGCACCGGCCTACACGGAGCGCGCGCGGCGGAGTTGTTGACGCTAGGGCTCCGGCTCCCTGGTTGGGT
GTTCTTTCTGACGCGACAGGAGGAGGAGAATGTCCTGGTCCTGTCGTCCTCCTTTCGGGTTTCCCGTGCACTCA
AACCGAGGACTTACAGAACGGAGGATAAAGTTAGGCCATTTTTACTCAGCTTCGGAGTTCAGGCTCATTTTTCAG
CTAAAGTCTCTCATTAGTATCCCCCCACACACATCGGGAAAATGGTTTGTCCTACGCATCGGTAATGAAGGCGG
GGCCCTTCGGGTCCTCCGGAGCGGGTTCCGGGGGTGGGGGGAAGGAGGGAGGGACGGGACGGGCCTCGTTC
ATGAATATTCAGTTCACCGCTGAATATGCATAAGGCAGGCAAGATGGCGCGTCCAATCAATTGGAAGTAGCCGT
TATTAGTGGAGAGGCCCCAGGACGTTGGGGCACCGCCTGTGCTCTAGTAGCTTTACGGAGCCCTGGCGCTCGA
TGTTCAAGCCCAAGCTTTCGCGAGCTCGACCGAACAAACGACCCAACACCCGTGCGTTTTATTCTGTCTTTTTAT
TGCCGCTCAGCTTTACAGTGACAATGACGGCTGGCGACTGAATATTAGTGCTTACAGACAGCACTACATATTTTC
CGTCGATGTTGAAATCCTTTCTCATATGTCACCATAAATATCAAATAATTATAGCAATCATTTACGCGTTAATGGCT
AATCGCCATCTTCCAGCAGGCGCACCATTGCCCCTGTTTCACTATCCAGGTTACGGATATAGTTCATGACAATAT
TTACATTGGTCCAGCCACCAGCTTGCATGATCTCCGGTATTGAAACTCCAGCGCGGGCCATATCTCGCGCGGCT
CCGACACGGGCACTGTGTCCAGACCAGGCCAGGTATCTCTGACCAGAGTCATCCTAAAATACACAAACAATTAG
AATCAGTAGTTTAACACATTATACACTTAAAAATTTTATATTTACCTTAGCGCCGTAAATCAATCGATGAGTTGCTT
CAAAAATCCCTTCCAGGGCGCGAGTTGATAGCTGGCTGGTGGCAGATGGCGCGGCAACACCATTTTTTCTGACC
CGGCAAAACAGGTAGTTATTCGGATCATCAGCTACACCAGAGACGGAAATCCATCGCTCGACCAGTTTAGTTAC
CCCCAGGCTAAGTGCCTTCTCTACACCTGCGGTGCTAACCAGCGTTTTCGTTCTGCCAATATGGATTAACATTCT
CCCACCGTCAGTACGTGAGATATCTTTAACCCTGATCCTGGCAATTTCGGCTATACGTAACAGGGTGTTATAAGC
AATCCCCAGAAATGCCAGATTACGTATATCCTGGCAGCGATCGCTATTTTCCATGAGTGAACGAACCTGGTCGAA
ATCAGTGCGTTCGAACGCTAGAGCCTGTTTTGCACGTTCACCGGCATCAACGTTTTCTTTTCGGATCCGCCGCAT
AACCAGTGAAACAGCATTGCTGTCACTTGGTCGTGGCAGCCCGGACCGACGATGAAGCATGTTTAGCTGGCCC
AAATGTTGCTGGATAGTTTTTACTGCCAGACCGCGCGCCTGAAGATATAGAAGATAATCGCGAACATCTTCAGGT
TCTGCGGGAAACCATTTCCGGTTATTCAACTTGCACCATGCCGCCCACGACCGGCAAACGGACAGAAGCATTTT
CCAGGTATGCTCAGAAAACGCCTGGCGATCCCTGAACATGTCCATCAGGTTCTTGCGAACCTCATCACTCGTTG
CATCGACCGGTAATGCAGGCAAATTTTGGTGTACGGTCAGTAAATTGGACACCTTCCTCTTCTTCTTGGGCATGG
CCGCAGGAAAGCAGAGCCCTGAAGCTCCCATCACCGGCCAATAAGAGCCAAGCCTGCAGTGTGACCTCATAGA
GCAATGTGCCAGCCAGCCTGACCCCAAGGGCCCTCAGGCTTGGGCACACTGTCTCTAGGACCCTGAGAGAAAG
ACATACCCATTTCTGCTTAGGGCCCTGAGGATGAGCCCAGGGGTGGCTTGGCACTGAAGCAAAGGACACTGGG
GCTCAGCTGGCAGCAAAGTGACCAGGATGCTGAGGCTTTGACCCAGAAGCCAGAGGCCAGAGGCCAGGACTT
CTCTTGGTCCCAGTCCACCCTCACTCAGAGCTTTACCAATGCCCTCTGGATAGTTGTCGGGTAACGGTGGACGC
CACTGATTCTCTGGCCAGCCTAGGACTTCGCCATTCCGCTGATTCTGCTCTTCCAGCCACTGGCTGACCGGTTG
GAAGTACTCCAGCAGTGCCTTGGCATCCAGGGCATCTGAGCCTACCAGGTCCTTCAGTACCTCCTGCCAGGGC
CTGGAGCAGCCAGCCTGCAACACCTGCCTGCCAAGCAGAGTGACCACTGTGGGCACAGGGGACACAGGGTGG
GGCCCACAACAGCACCATTGTCCACTTGTCCCTCACTAGTAAAAGAACTCTAGGGTTGCGGGGGGTGGGGGAG
GTCTCTGTGAGGCTGGTAAGGGATATTTGCCTGGCCCATGGAGATCCATAACTTCGTATAATGTATGCTATACGA
AGTTATAAGCTTTCGCGAGCTCGA 
 
10.2.2 Plasmids & Genes 
 
M71 coding sequence (930 bp) 
ATGACTGCAGAGAATCAATCTACAGTGACAGAGTTTATCCTCGGGGGGCTAACTAACAGGCCAGAGCTCCAGCT
ACCCCTCTTCCTCCTCTTTCTGGGGATCTACGTAGTCACCATGGTAGGAAACCTGGGCATGATCACCTTGATTG
GACTCAACTCACAGCTTCACACCCCCATGTACTTCTTCCTCAGTAACCTGTCACTCGTGGATCTCTGCTACTCCT
CTGTCATTACCCCTAAAATGCTCATCAACTTTGTGTCCCAAAGAAACCTCATCTCCTATGTGGGATGCATGTCTCA
GCTATACTTCTTCCTGGTTTTCGTCATTGCTGAGTGTTACATGCTCACTGTGATGGCCTATGACCGCTATGTGGC
CATCTGTCAACCCTTGCTTTATAACATCATCATGTCTCCTGCCCTCTGCTCTCTGCTGGTGGCTTTTGTCTATGCC
GTAGGACTCATCGGTTCAGCAATTGAGACTGGCCTCATGTTGAAATTAAACTATTGTGAGGACCTCATCAGCCAC
TACTTCTGTGACATCCTCCCCCTCATGAAGCTCTCTTGCTCTAGTACCTATGATGTAGAAATGGCTGTCTTCTTTT
TAGCTGGATTTGACATTATCGTCACAAGCTTAACCGTACTCATTTCCTATGCATTCATCCTGTCCAGCATCCTTCG
CATCAGCTCCAATGAGGGCAGGTCCAAAGCCTTCAGCACCTGCAGCTCCCACTTTGCAGCTGTGGGCTTGTTCT
ATGGATCCACAGCATTCATGTACTTAAAGCCTTCTACAGCTAGTTCCCTGGCCCAGGAGAATGTAGCTTCTGTGT
TCTACACCACAGTGATCCCCATGTTCAACCCCCTGATCTACAGCCTGAGAAACAAGGAGGTGAAGACCGCACTG
GACAAAACACTGAGGAGAAAAGTCTTTTGA 
 
LA (4532bp) 
GATCTTCCAGAAGCAATGAGCTTCTCTGGCATCAGATTCACATTCCTGGGGTGTCATTTCCCTACTGAAAGAACC
AAGATTCTTGGTGAAATGAATGACTCAGCTCTGAAGAATGAAAAGAATGTGGTAAAGTCACAACATCTTGTCATA
CCAGATGGTAAGGAAGATATTAGAGACTAGTATATTAAGTTCAGAGACAAATTGAGAAGTCCAGAGACTGTCAAT
ACCTGGGGCAGTAGCTTACTGGTTAAGTGTGCGCACTGCTGTTGCTGAGCACCTGAGTGTGGTTCTCAGCACAT
AGCTCAACTTATAACTCAAGGTCCAAGGGGGAATTTATTGCTGTCCCCTCCAAAGGTATTTGTGTTCATGTGAAC
ATACCAACACAGACACATGTACAATTTAAAATAATGAAAATAAAATGTAAAACATAAAATTAAATTCTGATAAAAGC
ATAGTAATTGTATTGGGCTGAAGCACATTAAATATGTTCACACTAGTGAATTTATAAAGGGGGGGATATAAGAAAC
CAACTATTGTTTTTAAATTATAAAACATATCTTTTTATTATAACTGTAATAGCAAATACAGGAACTATTCTGTTGAAT
AGATAGCACAAAAATAAGCACCAAAATGAGTGTGATTAAAATTGGAGAGCTCTGAATAAAATTAAAACTAGTGTCA
ATATTCTGGCCATGATGAGTACAGCTGTTTTCAAAGACATTACTCTCTCCCCGGGAAGGAATTTTAGCAACAGGC
TTCCACTTTGTGCTTCAAGTTAAACTTGCAAAACAAAGAAGCCAGGACCTGAATTTGAGAAATAATGTGTGTCATT
TGTCTTTCTGTCCCTGAGTTGCCTCACTTGGCAAAACTTTGTTTCAACAAAACTCTTTAAAACAAGCATGTCAAGG
CTAGCTCATGATGCATCATGGTGACTAGCTAACAATATGTAATAACCATCATGGCACTGAGAATGATGTTGCTGG
TAGTTACTGTGGTGCCTATTGAGATGAAAATGACAATAATGATAATACATCAGTAGTAAAGGTGATAGCCATGGT
CATAATGGTAATGATGATAAGGATGGGTGGGTAGTGGTGATGGATGGTTGGTGGTGGTGGTGGTGATGGTAGT
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GGTAGGGGGGTAATGGTGGTGGTAACGGCTCTGTTGATGCTAAATTGTTCATTGCCCCATTATATTCTAAGTTTC
TGAAACTGAAAGATGACTTTTACAGATAAAAGAAGAATTAACACACTTGGGAAATAAAACATGATTCACAGAACAA
GAGAAAACATGAACTAATTGTTACTTTAGAGACAACAATGGTCTCTAGAGTGACTATATCCCAGGAGATGATCCA
CACACACACACACATATATATAAACAGAACCCCCAATTTTTAGTCATATTATATCACCTTTCCAAATGACAATCTCC
TTTTCTGGACTAGACTGGGCTCTTTAAGTAAATTTTGTGGTGTATACACATCTGCATACTTCTAGAATTTACTGAAT
ATTGAAGCCACAGACATTGCCTGAAGTTTCATTTGAGACGCTGTTTCATTTCCTTCAGCACAGGTATTTTGTCTAA
AAATTAGATGAGAAAATATCTTCTCTTGTGAGCTCTTCTTTATAGTTTAGACTATTTATGACCATATGTTGACAGTT
AACTTTTAATGCTCTGTTCTATGTGATGTACTCTCTTCAGAAAAAATCCTGAGCTTCTGAAAGCTTGATAATAATAG
CTAATACACATAGGAACTCAGAAGGTATGTGTGGTCCTAGTTGGTCTTTTATATCATTAGAAAATTTAAGCTGTAC
CTGATAGCTAACACTGCTACCTGTATTTTCAGCACTTGGTCAGCTAAGGCAGGAGAATCATTACAAGCTGAAGGT
TAACCTGGGCTTTGGAGTGAGATCTTGTCTCAAAAAACAGTAGTGGGAGACCTGGAGAGGTGGCTCAGCAGTTA
AGAGCACTGACTGCTCATCCAGAGGTCATGAGTTCAAATCCCAAAAACCATCTGTAATGAGATCTGATGCCCTCT
TCTGGTGTATCTGAAGACAGCAACAGCAACAGTGTATTCATAAGCATAAAATAAATAAATACATCTTTAAAAAGAA
TCAGTAGTGGGGAAAAAGACAAGAATAAAAAGCTGCAGAAGAAGATTATATAAGCAAAAAAAAAAATTGAGACTA
GCTGTCTGAGCTCATTCTACAAGAATGTATTCTCATCTACATTGCACTGGGTATATAACATTTACCCTGACCTGAT
TTACAAAGTATTTTAATCTCTGCTAATGGTTACTGAATATGTTTCTTATAATATTAAGAAGCAGAGATTCCATAAAG
AGGGATAGGTAATATTTTTAATTATTCATCATCTAGATAAAAATCATTTTGTAGCCGGGCTTGGTGGCACACGCCT
TTAATCCCAGCACTTGGGAGGCAGAGGCAGGCAGATTTCTGAGTTCAAGGCCAGCCTGGTCTACAAGGTGAGTT
CCAGGACAGCCAGGGCTATACAGAGAAACTCTGTCTCAAAAATTAAAAAAAGATCATTTTGTAGTAAATAAAAATA
ATATTCAAGATCATACCGATCTGTGATATGTCAATATGTAACTTTAGTTAAGAAACGTTCTATCACTAATTCAATAT
GTAAACCCTACATATAACACATATGTTCTAATATTCAAAATATTCCAAAGATGTTAAAGATTCTCTTATACTTAAGA
AAAAGGAAGTCACTTGACTCAGTAGATAAAGCCATTTTCCATCAAATCTTAAAACTTGAGTTTTATCCCTAGAAGC
TTTAAGAAACAAGGAGAAAGCCAATTTCTGCAAGTTGTATATACACACACAACACAGCACAGCACACTCGCTATA
CACAAAATCTCTTTTCACAAAACTGGTACTATAAGTGACTTTTGAAAGAATGAACTGAAGATGTGTCAATAATTAAT
AATTGTATCAAAAACAATTACCATAGTGAGATTCCTGCTATGCCTTAAGAAATGTATCCCATACTGTACAGGGGCA
GCACATGGCTGCAATCCCAGCCAGCAGGAAGAAGAAGAAGGGGTAAGTTCAAGGAAAACCAATGCTACATAGA
AAGACTTAACTTTCAAAAAAAGAAAAAGAAAAATAGAAAGAAATAGAGAATAATACCTCAGATATGAGAATTTAATT
TAATATGTATCACATCTACTAATAACAACACATGCTTCTTAGGAAAATATACTATATATGTATATATAATATGTATGA
TTTGACATAGTGATAAATGGTGCAATGGTTTAGGATCTAAAAATAATAGCTAAAATTAACAACAAAGTGCTTGCTG
ATCCCACAATAAGCAACTACTCATCAAATATGACAGGACAGCAGTAAGAAATACAGAACTTGGCCCTTTACTAAG
CTTTAAGGCCTCTGAAACCCTAAGGGCTGGTCCTTCTGTCAGCAAGAAGCAACAGTATAGAGAAGATATGTGTG
CCACAGCCAGAATAGCTCAGCAAGTGTCAAATGCAGAAAACCAGCTCTCCAAGCAGGGCAAGAACAGCCATTCA
CAAACTCCTTCTCTCCCACCACACAGGCTTCCCACCCAGACACAATGACTGCAGAGAATCAATCTACAGTGACA
GAGTTTATCCTCGGGGGGCTAACTAACAGGCCAGAGCTCCAGCTACCCCTCTTCCTCCTCTTTCTGGGGATCCT
CGTAGTCACCATGGTAGGAAACCTGGGCATGATCACCTTGATTGGACTCAACTCACAGCTTCACACCCCCATGT
ACTTCTTCCTCAGTAACCTGTCACTCGTGGATCTCTGCTACTCCTCTGTCATTACCCCTAAAATGCTCATCAACTT
TGTGGCCCAAAGAAACCTCATCTCCTATGTGGGGTGCATGTCTCAGCTATACTTCTTCCTGGTTTTCGTCATTGC
TGAGTGTTACATGCTCACTGTGATGGCCTATGACCGCTATGTGGCCATCTGTCAACCCTTGCTTTATAACATCAT
CATGTCTCCTGCCCTCTGCTCTCTGCTGGTGGCTTTTGTCTATGCCGTAGGACTCATCGGTTCAGCAATTGAGAC
TGGCCTCATGTTGAAATTAAACTATTGTGAGGACCTCATCAGCCACTACTTCTGTGACATCCTCCCCCTCATGAA
GCTCTCTTGCTCTAGTACCTATGATGTAGAAATGGCTGTCTTCTTTTTAGCTGGATTTGACATTATCGTCACAAGC
TTAACCGTACTCATTTCCTATGCATTCATCCTGTCCAGCATCCTTCGCATCAGCTCCAACGAGGGCAGGTCCAAA
GCCTTCAGCACCTGCAGCTCCCACTTTGCAGCTGTGGCTTGTTCTATGGATCCACAGCATTCATGTACTTAAAGC
CTTCTACAGCTAGTTCCCTGGCCCGGGAGAATGTAGCTTCTGTGTTCTACACCACAGTGATCCCCATGCTCAAC
CCCCTGATCTACAGCCTGAGAAACAAGGAGGTGAAGACCGCACTGGACAAAACACTGAGGAGAAAAGTCTTTTG
ATGT 
 
RA (3807bp) 
AAATGCTGATCTTTCTTCATGTAAAAGTAAGTGGTTATGCACACCTGTATGATAACCTCTGCAAGCTCACCCAACT
CTGAACAGGAAACAGGAATCATTGCTCTCCATTGTTGGGCTCAAGGCCAATCTCCTTGTCCTCATTCTCATCTTC
TCTACCATTGGTTCTATTTATAATTACTCGATTTTAAGATAATTTTTATATTATTGGGTCTCTGTCCTCTATATGAGG
CCAATGGTAAGCAATTTTATAATTTTTACTATTAATATTTCATCTATTATATAATGTATTTGATCATATTCACCCCCA
CCCTCTTCTTCTCTTTCATTATCACCCCCTATATATCTACCTCCCATTTTCATGTCCTCTTTTTTTTTTAATAACCAA
CTGCATCCAATTAATACTGTTTATATTCACATTAGTGTCTGGCCATGCATGGGAGCATGGGTAACCTACTAGCAA
ATCTCACACAAATTCATTTAATTAGTGGAATCTAAATTACTTCTAGGGTACTAGTTGCAAGTGATTCTGAGAAATG
CAGTTTCCAGCTTGTTGACACTAAATAGAATGTGTATTAAAGGGTTAGTAGGACAGTCTCACTTAAATAGCTTTTT
ACTCATTTTCTTCTGACCTTTCCCCAACAAAAGAAGAAATTGCTACCACTGTTGATATGCTCTAATTAGAACTAAA
GGTAGGAAACTATCTCAGAGGGAGACCTCTCGATGCAACAACAACAACAACAACAACAAAAAGGCAAAAGTGTA
ATTCTGAGTTAGAATACATGCCTGAAGAGGGTGAGGCACTGAATTTGACGTGATGTAATCAGTTTCACAATTTAC
TTATATTGGTTTTAAATATTGTAATCTGCAAAGTGGGCAAAACCAGGGAAAGATAATTCTGTGTTCCAGACAAGAC
AGAACAATCAGATCCAAATCTGTAGAGCAGGTTATTTCCACAGAAACATAGTGCTTCTCAGTTCAAGCTGCTCGC
CCAAATAAAGCTCTGGAGAGGCGACTTGTGAAGCATGGAACACCTCACTAGACTGCCCAAGGATTTTAGCCCAA
GAAAAGTCTTTGTCACCAGAGCTAGGACATTTAGTTTTATTTCCTGGTTAGTCATGAATTTTCCCTCTTAAACTTTA
CCTTTTCATAGAGTTGACTCCACTATACTTAGAACCACAAACTCTCACCGTCAACAACAGCATCCTCATTGTGAAT
ACCTTCCATGGAAAGACCAGAAGTCTTTTCTCTTTAGCCTTGACTTTACTTCAGTTTATTACAAGCACAAATGTATT
TTTTTCATTATTTGGAATTGATCAATTTGATGGCATTGTGCAAATTGCTTTACCAATTGGATGAATTTTCTCAAAAG
TGTAGTTTTTAAAGAGAAGTTTATTTTGAAGATCTTTATGAAACTGCCTATAATAGAGAGGAGCTGTGGCAGACTA
AACACCAAAAATCTTTCCTCTGCCTTTGTGCTAAAACTGTTGTTTCTAACACACGCACACAAAAATCTCCAACAGT
AGGCGTACATAATCTGGCATACATCACTGCTCTTAAAAACTTTTTAAACTGCCGGGCAGTGGTGGTGCATGTCTT
TAATCCCAGCATTTGGGAAGCAGAGGCAGGCAAATTTCTGAGTTCAAAGCCAGCCTGGTCTACAGAGAGAGTTC
CAGAACAGCCCAGGTTATACAACGAAACCCTGTCTCAAATAAATAAATAAATAAATAAATAAATAAATAAATAAATA
ACCTTTTAAACTAATGTTAGTATCTTCATGATCTCAAACTGATTTAGGAAAATAACGTGTCCTTCTTTAGTGTTTGG
TATAGAGAGTATAGGCTCTTCACTAAATATTTACAGGAATCCTTTGTGAATAACTTCAAAGTATACAAGGCCATTC
CTAAATTTATAAGCTTGCACTATAGATTTTTGTTGAACTGTAGTCACACATCTTGTGGTTTTCAAAAATAGTATATC
TAACTTATGAAATGTATTATTAGCCCTTTTCTTCTTTTCCCCTTCTTTTCTCATGACTGAAGGTATGAAGCCAGTTC
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AATGATGTGTTCATCTGTGTACTAAATACTGATAGTGTTTGTGTGCACAAAGGCTAAAAAGGCAAAAATTTTTGGA
AGAAGAGTTTGCTCTACCTGAAACCTGTAAAATACAGTCTTTAAATGACTATGTAACAGTGAAAGGTTCTTTTGTA
CTAAGCACTTAGAAGGTGAGTGACAACAATGTAGGAGAAAACTAATTTAAGGTCATTTCCAGTCCTTCCTCTTAG
CCACTCAAGAGTACAACTGTCCATCACTCCTAAAATGTCCACCCTCTTGAACATCTGTGAAATTCCCTTTTTCCCT
TAATTACCTTCTAAATAGTCTCAATTCCTCACATATACCTTCTATTTTATTTTTTGCTTCTGGTCTTCACTAGGACAC
TGTGTCTGACAGTTTGGCCTTGCCCACCACATTCACATAGCTGTCGAGTAATGGCTCCACATCACCCAAGCCTTC
CCCAGCATCTCCGCTGTCAACAAGCTGATGCCTTTTATGGACATGTTAAGGGAAACTTTCAGCAGTGATTTTTTT
GTAGGTTTTCATCTAAGGGTTAGGTCTTATGAAGTTTCCTCAATCTACATTTATCAGCTGATGTCATTACACAGGT
CTTGTTGAGGTTGTCACAATTTTATAGGTGCAGCTTCTTCGTTGCCATATCCAAAGATGCTATCTCATAGCAGGTA
GCCGGTTCCTCTAGCTCTTATAATCTTTCCACCACTCTTCCATGATGATCCCTGAGACTTAAATATAGTGTCTACA
TGTAGTTGCGAATATCTGCCATAGTGTCAGATATGAATCCCCTCCTAGTTAGCAAGCCTTAAGACTTTGAGGTTG
TTGCCATTCCCTAGCTACTGTGAGTAAAGTGGAAATGAACACAGTCAAGCAAGTATCTGTTGAGGAGAACACCCA
GTCCTTTGGCAATATACCAAAGAAGAATACAGCTAGATCCTGTGATAATCCAGTTATAACTTTCTGTGAATCCTCC
ACAGTGATTACCATAGAGGCTTCCCTATTTGCAACCCTAGCAACAATCAATAAGTCTTTTTGCCTTTCTCTGAATC
CTAGACATTTGTTTCAGTTGTTTTCTTAATCCTAACCATCTGACTGGAGTAAGGCAAAATCTAAAAGCAGTTTTAAT
TTGCATTTTCATAGTTGCAAAGGAAGTTAAACACATTTTTACATATTTGTCAGCCATTTTTATTTCTTCCTCTGAGA
TCTTTCTCTTCAAATCCAGGGCCTATTAGGGGTGGGGAGTGGTCAGTTAATGACCTTAATGACTGAGCAAATGGA
GTCTTTCTCAGAAAGTCTTTTACTACATCTCTATCTTAGAGGGGACTGCCTGTGTACTCTTCAAGCGGTTTTAGCA
TTTAACGTTGCCCATGGAAGTTTTTGATCCATTTGGAATTTTTGTACCAAATAATAGATGTGGGACTATTTTTATTC
TTCTACATGTGGACATCCAGTTTTACCAGCACAATTTGTTGAAGAGTTTGTCTTTATACCAGTGTATATGTTTAACA
TTTTTGTCAAATATCAGATGGCTAAACTCATGTTTCAGTTTTCTGTTCTGTTACTCTGATTTAAATGCCTGTTGGTT
TGGCCATTTATTTTGCTTTGTTTTGTTGCCAGTACCATGCAATTTTTATTACTATAGCTCTATAACACTGGTTGAAA
CTGTGTTCTATCTCTCTAGCATTGTTCTTTCTGCTCAGGATTTCTTTGGTTATCCTTAGTCTCTTATGGTTCCATAT
GG 
 
pBluescript Phagemid Vector (2015) 
http://www.genomics.agilent.com/GenericB.aspx?PageType=Vector&SubPag
eType=Vector&PageID=32 
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